Table of Contents
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,

Washington, D.C. 20549

FORM 10-Q

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period endedJanuary 31, 2018

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission file number: 001-38175

Aspen Group, Inc.

(Exact name of registrant as specified in its charter)

2023
or

Delaware

27-1933597

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________
Commission file number 001-38175
AGI Logo.jpg
ASPEN GROUP, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware27-1933597
State or other jurisdictionOther Jurisdiction of incorporationIncorporation or organization)

Organization

(

I.R.S. Employer Identification No.)

1660 S Albion Street,

276 Fifth Avenue, Suite 525

Denver, CO

505
, New York, New York

80222

10001

(

Address of principal executive offices)

Principal Executive Offices

(

Zip Code)

Code

Registrants

(646) 448-5144
(Registrant’s telephone number: (303) 333-4224

number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 daysdays.  Yes þ     No o

¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes þ    No o

¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer ¨

Accelerated filer þ

¨

Non-accelerated filer ¨

(Do not check if a smaller

Smaller reporting company þ

reporting company)

Emerging growth company ¨


If an emerging growth company, indicate by checkmarkcheck mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o    No þ

Class

Outstanding as of March 15, 2018

May 12, 2023

Common Stock, $0.001 par value per share

15,072,332

25,462,316 shares






INDEX


Table of Contents
TABLE OF CONTENTS

Page Number

Consolidated StatementStatements of Changes in Stockholders’ Equity (Unaudited)

5

7

19

26

26

27

27

27

27

27

27

27


28









Table of Contents
PART I. FINANCIAL INFORMATION


ITEM 1. FINANCIAL STATEMENTS


ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


 

 

January 31,

 

 

April 30,

 

 

 

2018

 

 

2017

 

 

 

(Unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

3,803,080

 

 

$

2,756,217

 

Restricted cash

 

 

190,506

 

 

 

 

Accounts receivable, net of allowance of $544,492 and $328,864, respectively

 

 

8,592,958

 

 

 

4,434,862

 

Prepaid expenses

 

 

288,640

 

 

 

133,531

 

Promissory note receivable

 

 

 

 

 

900,000

 

Other receivables

 

 

233,862

 

 

 

81,464

 

Accrued interest receivable

 

 

 

 

 

8,000

 

Total current assets

 

 

13,109,046

 

 

 

8,314,074

 

 

 

 

 

 

 

 

 

 

Property and equipment:

 

 

 

 

 

 

 

 

Call center equipment

 

 

96,305

 

 

 

53,748

 

Computer and office equipment

 

 

130,137

 

 

 

103,649

 

Furniture and fixtures

 

 

712,209

 

 

 

255,984

 

Software

 

 

2,590,297

 

 

 

2,131,344

 

 

 

 

3,528,948

 

 

 

2,544,725

 

Less accumulated depreciation and amortization

 

 

(1,161,030

)

 

 

(1,090,010

)

Total property and equipment, net

 

 

2,367,918

 

 

 

1,454,715

 

Goodwill

 

 

5,011,432

 

 

 

 

Intangible assets, net

 

 

9,916,667

 

 

 

 

Courseware, net

 

 

137,557

 

 

 

145,477

 

Accounts receivable, secured - related party, net of allowance of $625,963, and $625,963, respectively

 

 

45,329

 

 

 

45,329

 

Long term contractual receivable

 

 

935,878

 

 

 

657,542

 

Other assets

 

 

585,206

 

 

 

56,417

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

32,109,033

 

 

$

10,673,554

 


January 31, 2023April 30, 2022
(Unaudited)
Assets
Current assets:
Cash and cash equivalents$1,603,501 $6,482,750 
Restricted cash4,923,525 6,433,397 
Accounts receivable, net of allowance of $3,622,365 and $3,460,288, respectively22,517,343 24,359,241 
Prepaid expenses925,890 1,358,635 
Other current assets1,050,307 748,568 
Total current assets31,020,566 39,382,591 
Property and equipment:
Computer equipment and hardware1,584,826 1,516,475 
Furniture and fixtures2,219,245 2,193,261 
Leasehold improvements8,046,844 7,179,896 
Instructional equipment756,568 715,652 
Software11,306,700 10,285,096 
Construction in progress— 2,100 
23,914,183 21,892,480 
Less: accumulated depreciation and amortization(11,102,309)(8,395,001)
Total property and equipment, net12,811,874 13,497,479 
Goodwill5,011,432 5,011,432 
Intangible assets, net7,900,000 7,900,000 
Courseware, net288,024 274,047 
Long-term contractual accounts receivable16,280,621 11,406,525 
Deferred financing costs155,041 369,902 
Operating lease right-of-use assets, net13,865,872 12,645,950 
Deposits and other assets501,190 578,125 
Total assets$87,834,620 $91,066,051 
(Continued)



The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.





1



Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)


 

 

January 31,

 

 

April 30,

 

 

 

2018

 

 

2017

 

 

 

(Unaudited)

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

1,273,990

 

 

$

756,701

 

Accrued expenses

 

 

596,633

 

 

 

262,911

 

Deferred revenue

 

 

4,156,550

 

 

 

1,354,989

 

Refunds due students

 

 

730,722

 

 

 

310,576

 

Deferred rent, current portion

 

 

7,429

 

 

 

11,200

 

Convertible notes payable- related party, current portion

 

 

1,000,000

 

 

 

 

Convertible notes payable, current portion

 

 

50,000

 

 

 

50,000

 

Other current liabilities

 

 

186,134

 

 

 

 

Total current liabilities

 

 

8,001,458

 

 

 

2,746,377

 

 

 

 

 

 

 

 

 

 

Convertible note payable - related party

 

 

1,000,000

 

 

 

 

Senior secured term loan, net of discount

 

 

6,769,932

 

 

 

 

Warrant Liability

 

 

 

 

 

52,500

 

Deferred rent

 

 

60,295

 

 

 

34,437

 

Total liabilities

 

 

15,831,685

 

 

 

2,833,314

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies - See Note 7

 

 

— 

 

 

 

— 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock, $0.001 par value; 250,000,000 shares authorized,

 

 

 

 

 

 

 

 

15,072,332 issued and 15,055,665 outstanding at January 31, 2018

 

 

 

 

 

 

 

 

13,504,012 issued and 13,487,345 outstanding at April 30, 2017

 

 

15,072

 

 

 

13,504

 

Additional paid-in capital

 

 

45,439,538

 

 

 

33,607,423

 

Treasury stock (16,667 shares)

 

 

(70,000

)

 

 

(70,000

)

Accumulated deficit

 

 

(29,107,262

)

 

 

(25,710,687

)

Total stockholders’ equity

 

 

16,277,348

 

 

 

7,840,240

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

32,109,033

 

 

$

10,673,554

 







January 31, 2023April 30, 2022
(Unaudited)
Liabilities and Stockholders’ Equity
Liabilities:
Current liabilities:
Accounts payable$2,247,043 $1,893,287 
Accrued expenses3,118,533 2,821,432 
Deferred revenue8,075,063 5,889,911 
Due to students2,977,365 4,063,811 
Current portion of long-term debt5,000,000 — 
Operating lease obligations, current portion2,346,766 2,036,570 
Other current liabilities306,484 130,262 
Total current liabilities24,071,254 16,835,273 
Long-term debt, net9,957,328 14,875,735 
Operating lease obligations, less current portion17,869,754 16,809,319 
Total liabilities51,898,336 48,520,327 
Commitments and contingencies – see Note 10
Stockholders’ equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized,
0 issued and 0 outstanding at January 31, 2023 and April 30, 2022— — 
Common stock, $0.001 par value; 60,000,000 shares authorized,
25,586,837 issued and 25,431,351 outstanding at January 31, 2023
25,357,764 issued and 25,202,278 outstanding at April 30, 202225,587 25,358 
Additional paid-in capital113,035,546 112,081,564 
Treasury stock (155,486 at both January 31, 2023 and April 30, 2022)(1,817,414)(1,817,414)
Accumulated deficit(75,307,435)(67,743,784)
Total stockholders’ equity35,936,284 42,545,724 
Total liabilities and stockholders’ equity$87,834,620 $91,066,051 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.




2



Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


 

 

For the

 

 

For the

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

January 31,

 

 

January 31,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

  

                     

  

  

                     

  

  

                     

  

  

                     

  

Revenues

 

$

5,701,958

 

 

$

3,735,626

 

 

$

14,796,483

 

 

$

9,957,467

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues (exclusive of depreciation and amortization shown separately below)

 

 

2,665,664

 

 

 

1,359,131

 

 

 

6,282,814

 

 

 

3,490,046

 

General and administrative

 

 

4,677,359

 

 

 

2,133,074

 

 

 

10,975,085

 

 

 

6,228,554

 

Program review settlement expense

 

 

 

 

 

25,000

 

 

 

 

 

 

25,000

 

Depreciation and amortization

 

 

347,894

 

 

 

132,727

 

 

 

631,969

 

 

 

422,782

 

Total operating expenses

 

 

7,690,917

 

 

 

3,649,932

 

 

 

17,889,868

 

 

 

10,166,382

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating (loss) income

 

 

(1,988,959

)

 

 

85,694

 

 

 

(3,093,385

)

 

 

(208,915

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income

 

 

46,179

 

 

 

1,684

 

 

 

88,067

 

 

 

3,047

 

Gain on extinguishment of warrant liability

 

 

52,500

 

 

 

 

 

 

52,500

 

 

 

 

Interest expense

 

 

(257,665

)

 

 

(80,001

)

 

 

(443,757

)

 

 

(175,662

)

Total other expense, net

 

 

(158,986

)

 

 

(78,317

)

 

 

(303,190

)

 

 

(172,615

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) income before income taxes

 

 

(2,147,945

)

 

 

7,377

 

 

 

(3,396,575

)

 

 

(381,530

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(2,147,945

)

 

$

7,377

 

 

$

(3,396,575

)

 

$

(381,530

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share allocable to common stockholders - basic

 

$

(0.15

)

 

$

0.00

 

 

$

(0.25

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share allocable to common stockholders - diluted

 

$

(0.15

)

 

$

0.00

 

 

$

(0.25

)

 

$

(0.03

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding: basic

 

 

14,491,634

 

 

 

11,467,345

 

 

 

13,862,992

 

 

 

11,419,270

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding: diluted

 

 

14,491,634

 

 

 

13,040,970

 

 

 

13,862,992

 

 

 

11,419,270

 





Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Revenue$15,574,042 $18,944,798 $51,542,502 $57,316,004 
Operating expenses:
   Cost of revenue (exclusive of depreciation and amortization shown separately below)5,394,155 9,275,419 21,946,714 26,658,188 
   General and administrative9,624,528 11,771,487 31,039,666 34,359,276 
   Bad debt expense450,000 350,000 1,250,000 1,050,000 
   Depreciation and amortization919,152 883,536 2,775,330 2,480,179 
Total operating expenses16,387,835 22,280,442 57,011,710 64,547,643 
   Operating loss(813,793)(3,335,644)(5,469,208)(7,231,639)
Other income (expense):
   Interest expense(716,845)(180,697)(2,008,510)(353,738)
   Other income, net12,847 13,954 28,138 516,754 
Total other (expense) income, net(703,998)(166,743)(1,980,372)163,016 
Loss before income taxes(1,517,791)(3,502,387)(7,449,580)(7,068,623)
Income tax expense37,249 231,610 114,071 388,520 
Net loss$(1,555,040)$(3,733,997)$(7,563,651)$(7,457,143)
Net loss per share - basic and diluted$(0.06)$(0.15)$(0.30)$(0.30)
Weighted average number of common stock outstanding - basic and diluted25,381,500 25,041,733 25,289,224 24,971,056 


The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.





3



Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTSTATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE NINE MONTHS ENDED JANUARY

Three Months Ended January 31, 2018

2023 and 2022

(Unaudited)


 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-In

 

 

Treasury

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Equity

 

Balance at April 30, 2017

 

 

13,504,012

 

 

$

13,504

 

 

$

33,607,423

 

 

$

(70,000

)

 

$

(25,710,687

)

 

$

7,840,240

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fees associated with equity raise

 

 

 

 

 

 

 

 

(14,033

)

 

 

 

 

 

 

 

 

(14,033

)

Restricted stock issued for services

 

 

10,000

 

 

 

10

 

 

 

88,690

 

 

 

 

 

 

 

 

 

88,700

 

Stock-based compensation

 

 

 

 

 

 

 

 

466,468

 

 

 

 

 

 

 

 

 

466,468

 

Common stock issued for acquisition

 

 

1,203,209

 

 

 

1,203

 

 

 

10,214,041

 

 

 

 

 

 

 

 

 

10,215,244

 

Common stock issued for cashless warrant exercises

 

 

162,072

 

 

 

162

 

 

 

(162

)

 

 

 

 

 

 

 

 

 

Common stock issued for warrants exercised for cash

 

 

79,442

 

 

 

79

 

 

 

143,410

 

 

 

 

 

 

 

 

 

143,489

 

Common stock issued for stock options exercised

 

 

113,597

 

 

 

114

 

 

 

455,273

 

 

 

 

 

 

 

 

 

455,387

 

Warrants issued with senior secured term loan

 

 

 

 

 

 

 

 

478,428

 

 

 

 

 

 

 

 

 

478,428

 

Net loss, for the Nine months ended January 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,396,575

)

 

 

(3,396,575

)

Balance at January 31, 2018

 

 

15,072,332

 

 

$

15,072

 

 

$

45,439,538

 

 

$

(70,000

)

 

$

(29,107,262

)

 

$

16,277,348

 






Common StockAdditional
Paid-In
Capital
Treasury
Stock
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at October 31, 202225,460,849 $25,461 $112,634,162 $(1,817,414)$(73,752,395)$37,089,814 
Stock-based compensation— — 394,510 — — 394,510 
Common stock issued for vested restricted stock units125,988 126 (126)— — — 
Amortization of warrant-based cost issued for services— — 7,000 — — 7,000 
Net loss— — — — (1,555,040)(1,555,040)
Balance at January 31, 202325,586,837 $25,587 $113,035,546 $(1,817,414)$(75,307,435)$35,936,284 
Common StockAdditional
Paid-In
Capital
Treasury
Stock
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at October 31, 202125,148,194 $25,149 $110,526,729 $(1,817,414)$(61,881,149)$46,853,315 
Stock-based compensation— — 700,697 — — 700,697 
Common stock issued for stock options exercised for cash41,667 41 134,959 — — 135,000 
Common stock issued for vested restricted stock units38,719 39 (39)— — — 
Amortization of warrant based cost— — 16,125 — — 16,125 
Net loss— — — — (3,733,997)(3,733,997)
Balance at January 31, 202225,228,580 $25,229 $111,378,471 $(1,817,414)$(65,615,146)$43,971,140 



The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.




















4

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

CHANGES IN STOCKHOLDERS’ EQUITY

Nine Months Ended January 31, 2023 and 2022
(Unaudited)


 

 

For the

 

 

 

Nine months ended

 

 

 

January 31,

 

 

 

2018

 

 

2017

 

Cash flows from operating activities:

  

                     

  

  

                     

  

Net loss

 

$

(3,396,575

)

 

$

(381,530

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Bad debt expense (recovery)

 

 

298,144

 

 

 

(25,680

)

Gain on extinguishment of warrant liability

 

 

(52,500

)

 

 

 

Depreciation and amortization

 

 

631,969

 

 

 

422,782

 

Loss on asset disposal

 

 

27,590

 

 

 

 

Stock-based compensation

 

 

466,468

 

 

 

253,833

 

Amortization of debt discounts

 

 

99,726

 

 

 

15,625

 

Amortization of prepaid shares for services

 

 

37,039

 

 

 

52,500

 

Warrant buyback expense

 

 

 

 

 

206,000

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

  

 

Accounts receivable

 

 

(4,534,118

)

 

 

(2,331,140

)

Prepaid expenses

 

 

(59,451

)

 

 

28,715

 

Accrued interest receivable

 

 

(45,400

 

 

 

Other receivables

 

 

(152,398

 

 

 

Other assets

 

 

(528,789

)

 

 

(25,241

)

Accounts payable

 

 

366,044

 

 

 

875,110

 

Accrued expenses

 

 

218,476

 

 

 

105,111

 

Deferred rent

 

 

22,087

 

 

 

17,318

 

Refunds due students

 

 

420,146

 

 

 

124,912

 

Deferred revenue

 

 

2,340,461

 

 

 

562,643

 

Other liabilities

 

 

186,134

 

 

 

 

Net cash used in operating activities

 

 

(3,654,947

)

 

 

(99,042

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Cash paid in asset acquisition

 

 

(2,589,719

)

 

 

 

Proceeds from promissory note interest receivable

 

 

53,400

 

 

 

 

Increase in restricted cash

 

 

(190,506

)

 

 

 

Purchases of courseware

 

 

(33,369

)

 

 

(6,550

)

Purchases of property and equipment

 

 

(1,171,473

)

 

 

(565,306

)

Proceeds from promissory note receivable

 

 

900,000

 

 

 

 

Net cash used in investing activities

 

 

(3,031,667

)

 

 

(571,856

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Warrant Buyback

 

 

 

 

 

(400,000

)

Borrowing of bank line of credit

 

 

 

 

 

247,000

 

Payments for bank line of credit

 

 

 

 

 

(248,783

)

Borrowing of third party line of credit

 

 

 

 

 

1,250,000

 

Third party line of credit financing costs

 

 

 

 

 

(60,000

)

Proceeds of warrant and stock options exercised

 

 

598,876

 

 

 

 

Offering costs paid on debt financing

 

 

(351,366

 

 

 

Disbursements for equity offering costs

 

 

(14,033

)

 

 

(4,017

)

Proceeds from senior secured term loan

 

 

7,500,000

 

 

 

 

Net cash provided by financing activities

 

 

7,733,477

 

 

 

784,200

 

 

 

 

 

 

 

 

 

 

Net increase in cash

 

 

1,046,863

 

 

 

113,302

 

Cash at beginning of period

 

 

2,756,217

 

 

 

783,796

 

Cash at end of period

 

$

3,803,080

 

 

$

897,098

 


(Continued)




Common StockAdditional
Paid-In
Capital
Treasury
Stock
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at April 30, 202225,357,764 $25,358 $112,081,564 $(1,817,414)$(67,743,784)$42,545,724 
Stock-based compensation— — 899,176 — — 899,176 
Common stock issued for vested restricted stock units192,233 192 (192)— — — 
Common stock issued for services25,000 25 24,475 — — 24,500 
Common stock issued for equity raise, net of underwriter costs11,840 12 9,523 — — 9,535 
Amortization of warrant-based cost issued for services— — 21,000 — — 21,000 
Net loss— — — — (7,563,651)(7,563,651)
Balance at January 31, 202325,586,837 $25,587 $113,035,546 $(1,817,414)$(75,307,435)$35,936,284 
Common StockAdditional
Paid-In
Capital
Treasury
Stock
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at April 30, 202125,066,297 $25,067 $109,040,824 $(1,817,414)$(58,158,003)$49,090,474 
Stock-based compensation— — 1,965,567 — — 1,965,567 
Common stock issued for stock options exercised for cash58,419 58 190,976 — — 191,034 
Common stock issued for cashless stock options exercised30,156 30 (30)— — — 
Common stock issued for vested restricted stock units73,708 74 (74)— — — 
Amortization of warrant based cost— — 43,708 — — 43,708 
Warrants issued for deferred financing costs related to Credit Facility— — 137,500 — — 137,500 
Net loss— — — — (7,457,143)(7,457,143)
Balance at January 31, 202225,228,580 $25,229 $111,378,471 $(1,817,414)$(65,615,146)$43,971,140 





The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.




5



Table of Contents


ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(Unaudited)


 

 

For the

 

 

 

Nine months ended

 

 

 

January 31,

 

 

 

2018

 

 

2017

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

316,781

 

 

$

145,105

 

Cash paid for income taxes

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing activities

 

 

 

 

 

 

 

 

Warrants issued as part of senior secured loan

 

$

478,428

 

 

$

 

Assets acquired net of liabilities assumed for non-cash consideration

 

$

12,215,244

 

 

$

 

Common stock issued for services

 

$

 

 

$

62,002

 

Warrant derivative liability

 

$

 

 

$

52,500

 


Nine Months Ended January 31,
 20232022
Cash flows from operating activities:
Net loss$(7,563,651)$(7,457,143)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense1,250,000 1,050,000 
Depreciation and amortization2,775,330 2,480,179 
Stock-based compensation899,176 1,965,567 
Amortization of warrant-based cost21,000 43,708 
Amortization of deferred financing costs468,787 49,107 
Amortization of debt discounts88,500 18,056 
Common stock issued for services24,500 — 
Loss on asset disposition— 36,445 
Non-cash lease benefit(267,290)(96,450)
Tenant improvement allowances received from landlords418,000 816,591 
Changes in operating assets and liabilities:
Accounts receivable(4,282,195)(6,412,590)
Prepaid expenses432,745 (297,797)
Other current assets(301,738)37,498 
Accounts receivable, other— 45,329 
Deposits and other assets76,934 (44,686)
Accounts payable(68,244)340,168 
Accrued expenses297,101 38,353 
Due to students(1,086,446)482,032 
Deferred revenue2,185,152 (642,233)
Other current liabilities176,222 (171,894)
Net cash used in operating activities(4,456,117)(7,719,760)
Cash flows from investing activities:
Purchases of courseware and accreditation(82,000)(161,262)
Disbursements for reimbursable leasehold improvements(418,000)(816,591)
Purchases of property and equipment(1,181,706)(2,756,817)
Net cash used in investing activities(1,681,706)(3,734,670)
Cash flows from financing activities:
Proceeds from sale of common stock, net of underwriter costs9,535 — 
Payment of commitment fee for 2022 Credit Facility(200,000)— 
Payments of deferred financing costs(60,833)— 
Borrowings under the 2018 Credit Facility— 5,000,000 
Proceeds from stock options exercised— 191,034 
Net cash (used in) provided by financing activities(251,298)5,191,034 


(Continued)
The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.








6

Table of Contents

ASPEN GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(Unaudited)
Nine Months Ended January 31,
20232022
Net decrease in cash, cash equivalents and restricted cash$(6,389,121)$(6,263,396)
Cash, cash equivalents and restricted cash at beginning of period12,916,147 13,666,079 
Cash, cash equivalents and restricted cash at end of period$6,527,026 $7,402,683 
Supplemental disclosure cash flow information:
Cash paid for interest$1,446,728 $258,630 
Cash paid for income taxes$25,253 $13,520 
Supplemental disclosure of non-cash investing and financing activities:
Warrants issued as part of the 2018 Credit Facility amendment$— $137,500 

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying consolidated balance sheet to the total amounts shown in the accompanying unaudited consolidated statements of cash flows:
January 31,
20232022
Cash and cash equivalents$1,603,501 $5,969,286 
Restricted cash4,923,525 1,433,397 
Total cash, cash equivalents and restricted cash$6,527,026 $7,402,683 


The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.
7

Table of Contents

ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)




Note 1. Nature of Operations and Liquidity


Overview


Aspen Group, Inc. (together with its subsidiaries, the “Company” or “AGI”("AGI") is aan education technology holding company, whichcompany. AGI has two subsidiaries.subsidiaries, Aspen University Inc. (“("Aspen University”University" or "AU") was organized in 1987, and United States University Inc. (“USU”("United States University" or "USU") was formed May 2017.
All references to the “Company”, “AGI”, “Aspen Group”, “we”, “our” and certain assets were acquired“us” refer to Aspen Group, Inc., unless the context otherwise indicates.
AGI leverages its education technology infrastructure and liabilities assumedexpertise to allow its two universities, Aspen University and United States University, to deliver on December 1, 2017. (See Note 10)


Aspen Group’sthe vision is to makeof making college affordable again in America.again. Because we believe higher education should be a catalyst to our students’ long-term economic success, we exert financial prudence by offering affordable tuition that is one of the greatest values in online higher education.  In March 2014, Aspen University unveiled a monthly payment plan aimed at reversingAGI’s primary focus relative to future growth is to target the college-debt sentence plaguing working-class Americans. The monthly payment plan offers bachelor students (except RN to BSN) the opportunity to pay their tuition at $250/month for 72 months ($18,000),high growth nursing bachelor students (RN to BSN) $250/month for 39 months ($9,750), master students $325/month for 36 months ($11,700) and doctoral students $375/month for 72 months ($27,000), interest free, thereby giving students a monthly payment tuition payment option versus taking out a federal financial aid loan.


United States University (USU) began offering monthly payment plans in the summer of 2017.  Today, monthly payment plans are available for the RN to BSN program ($250/month), MBA/M.A.Ed/MSN programs ($325/month), and the MSN-FNP program ($375/month).


profession.

Since 1993, Aspen University has been nationallyinstitutionally accredited by the Distance Education and Accrediting Council (“DEAC”), a nationalan accrediting agency recognized by the U.S.United States Department of Education (the “DOE”). On February 25, 2015, the DEAC informed Aspen University that it had renewed its accreditation for five years to, through January 2019.


2024.

Since 2009, USU has been regionallyinstitutionally accredited by WASC Senior College and University Commission.Commission (“WSCUC”).


, an accrediting agency recognized by the DOE, through 2030.

Both universities are qualified to participate under the Higher Education Act of 1965, as amended (HEA)("HEA") and the Federal student financial assistance programs (Title IV, HEA programs). USU hashad provisional certification resulting from the ownership change of control in connection with the acquisition by AGI on December 1, 2017. The provisional certification expired on December 31, 2020. The institution submitted its recertification application timely in October 2020, and received full certification on May 6, 2022, and a new Program Participation Agreement ("PPA") was issued with an effective period until December 31, 2025. On August 22, 2017, the DOE informed Aspen University of its determination that the institution had qualified to participate under the HEA and the Federal student financial assistance programs (Title IV, HEA programs) and set a subsequent program participation agreement reapplication date of March 31, 2021. On April 16, 2021, the DOE granted provisional certification.


certification for a two-year timeframe, and set a subsequent program participation reapplication date of September 30, 2023.


Basis of Presentation


A. Interim Financial Statements


The interim unaudited consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and nine months ended January 31, 20182023 and 2017,2022, our cash flows for the nine months ended January 31, 20182023 and 2017,2022, and our consolidated financial position as of January 31, 20182023 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.


Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the periodfiscal year ended April 30, 20172022 as filed with the SEC on July 25, 2017.29, 2022. The April 30, 20172022 consolidated balance sheet is derived from those statements.





7



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY 31, 2018

(Unaudited)



B. Liquidity


At January 31, 2018, the Company had a cash balance of $3,803,080 plus $190,506 in restricted cash.


On July 25, 2017, the Company signed a $10 million senior secured term loan with Runway Growth Capital Fund (formerly known as GSV Growth Capital Fund). The Company drew $5 million under the facility at closing, with an additional $2.5 million drawn following the closing of the Company’s acquisition of substantially all the assets of United States University, including receipt of all required regulatory approvals, among other conditions to funding. Terms of the 4-year senior loan include a 10% over 3-month LIBOR per annum interest rate. (See Notes 5 and 10).  


Note 2. Significant Accounting Policies


Principles

Basis of Consolidation



8

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

The unauditedCompany prepares its consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP").
The consolidated financial statements include the accounts of Aspen Group, Inc.AGI and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.


Use

A full listing of our significant accounting policies is described in Note 2. Summary of Significant Accounting Policies of our Annual Report on Form 10-K for the fiscal year ended April 30, 2022 as filed with the SEC on July 29, 2022.
Accounting Estimates


The

Management of the Company is required to make certain estimates, judgments and assumptions during the preparation of the unauditedits consolidated financial statements in conformityaccordance with accounting principles generally accepted in the United States of America (“GAAP”) requires management to makeGAAP. These estimates, judgments and assumptions that affectimpact the reported amounts inof assets, liabilities, revenue and expenses and the unaudited consolidated financial statements.related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.
Significant estimates in the accompanying unaudited consolidated financial statements include the allowance for doubtful accounts, and other receivables, the valuation of collateral on certain receivables,lease liabilities and the carrying value of the related right-of-use assets ("ROU assets"), depreciable lives of property and equipment, amortization periods and valuation of courseware, intangibles and software development costs, valuation of beneficial conversion features in convertible debt, valuation of goodwill, valuation of loss contingencies, valuation of stock-based compensation and the valuation allowance on deferred tax assets.


Cash, and Cash Equivalents,


and Restricted Cash

For the purposes of the unaudited consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at January 31, 2018 and April 30, 2017.
January 31, 2023April 30, 2022
Cash and cash equivalents$1,603,501 $6,482,750 
Restricted cash:
Letter of credit for level of Title IV funding at USU— 9,872 
Collateral for corporate credit card at AGI250,000 250,000 
Letters of credit for operating leases at AU and USU1,173,525 1,173,525 
Collateral for surety bond at AU3,500,000 5,000,000 
Total restricted cash4,923,525 6,433,397 
Total cash and cash equivalents and restricted cash as shown on the statement of cash flows$6,527,026 $12,916,147 
Concentration of Credit Risk
The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits of $250,000 per financial institution. The Company has not experienced any losses in such accounts from inception through January 31, 2018.2023. As of January 31, 20182023 and April 30, 2017, there were2022, the Company maintained deposits totaling $3,594,104exceeding federally insured limits by approximately $2,718,846 and $2,687,461$7,749,715, respectively, held in two separate institutions greaterthaninstitutions.
Revenue Recognition and Deferred Revenue
The Company follows Accounting Standards Codification 606 (ASC 606). ASC 606 is based on the federally insured limits.


Goodwill and Intangibles


Goodwill representsprinciple that revenue is recognized to depict the excesstransfer of purchase price overgoods or services to customers in an amount that reflects the fair market valueconsideration to which the entity expects to be entitled in exchange for those goods or services. This ASC also requires additional disclosure about the

9

Table of assets acquired and liabilities assumed from Educacion Significativa, LLC. Goodwill has an indefinite life and is not amortized. Goodwill is tested annually for impairment.


Intangibles represent both indefinite lived and definite lived assets. Accreditation and regulatory approvals and Trade name and trademarks are deemed to have indefinite useful lives and accordingly are not amortized but are tested annually for impairment.  Student relationships and curriculums are deemed to have definite lives and are amortized accordingly.



8



Contents

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



Fair Value Measurements


Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The Company classifies assets


nature, amount, timing, and liabilities recorded at fair value under the fair value hierarchy based upon the observabilityuncertainty of inputs used in valuation techniques. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. The fair value measurements are classified under the following hierarchy:


Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;

Level 2—Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and

Level 3—Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.


The estimated fair value of certain financial instruments, including cashrevenue and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.


Refunds Due Students


The Company receives Title IV fundsflows arising from the Department of Education to cover tuition and living expenses. After deducting tuition and fees, the Company sends checks for the remaining balances to the students.


customer purchase orders, including significant judgments.

Revenue Recognition and Deferred Revenue


Revenues consistconsists primarily of tuition and course fees derived from courses taught by the Company online and in-person as well as from related educational resources and services that the Company provides to its students, such as access to our online materialsstudents. Under ASC 606, tuition and learning management system. Tuitioncourse fee revenue is recognized pro-rata over the applicable period of instruction. The Company maintains an institutional tuition refund policy,instruction and are not considered separate performance obligations. Non-tuition related revenue and fees are recognized as services are provided or when the goods are received by the student. Students may receive discounts, scholarships, or refunds, which provides for allgives rise to variable consideration. Discounts or a portion of tuitionscholarships are applied to be refunded if aindividual student withdraws during stated refund periods. Certain states in which students reside impose separate, mandatory refund policies, which override the Company’s policy to the extent in conflict. If a student withdraws at a timeaccounts when a portion or none ofsuch amounts are awarded. Therefore, the tuition is refundable, then in accordance with its revenue recognition policy, the Company recognizes as revenue the tuition that was not refunded. Since the Company recognizes revenue pro-rata over the term of the course and because, under its institutional refund policy, the amount subject to refund is never greater thanreduced directly by these discounts or scholarships from the amount of the revenue that has been deferred, under the Company’s accounting policies revenue is not recognized with respect to amounts that could potentially be refunded. The Company’s educational programs have starting and ending dates that differ from its fiscal quarters. Therefore, at the end of each fiscal quarter, a portion of revenue from these programs is not yet earned and is therefore deferred. The Company also charges students annual fees for library, technology and other services, which are recognized over the related service period. standard tuition rate charged.

Deferred revenue, a contract liability, represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets. Other revenuesrevenue may be recognized as sales occur or services are performed.


The Company has revenues from students outside the United States representing 2.1% of the revenues for the quarter ended January 31, 2018.


Accounting for Derivatives


The Company evaluates its convertible instruments, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under ASC Topic 815, “Derivatives and Hedging”. The result of this accounting treatment is that the fair value of the derivative is marked-to-market each balance sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income (expense). Upon conversion, exercise, or other extinguishment (transaction) of a derivative instrument, the instrument is marked to fair value at the transaction date and then that fair value is recognized as an extinguishment gain or loss. Equity instruments that are initially classified as equity that become subject to reclassification under ASC Topic 815 are reclassified to liability at the fair value of the instrument on the reclassification date.



9



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY 31, 2018

(Unaudited)



Business Combinations


We include the results of operations of businesses we acquire from the date of the respective acquisition. We allocate the purchase price of acquisitions to the assets acquired and liabilities assumed at fair value. The excess of the purchase price of an acquired business over the amount assigned to the assets acquired and liabilities assumed is recorded as goodwill. We expense transaction costs associated with business combinations as incurred.


Net Income (Loss)Loss Per Share


Net income (loss)loss per common share is based on the weighted average number of shares of common sharesstock outstanding during each period. Options to purchase 2,872,546 and 1,963,481 commonSummarized below are shares warrants to purchase 743,773 and 934,555 common shares, and $50,000 and $350,000 of convertible debt (convertible into 4,167 and 75,596 common shares) were outstanding at January 31, 2018 and 2017, respectively, but were not included in the computation of diluted net loss per share because the effects would have been anti-dilutive. The options, warrants, RSUs, unvested restricted stock and convertible debtnotes are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share of common sharestock when their effect is dilutive,dilutive. See Note 6. Stockholders’ Equity.

January 31, 2023April 30, 2022
Options to purchase common shares614,458 860,182 
Restricted stock units— — 
Warrants to purchase common shares425,000 649,174 
Unvested restricted stock523,056 929,928 
Convertible Notes10,000,000 10,000,000 
Segment Information
The Company operates in one reportable segment as noted ina single educational delivery operation using a core infrastructure that serves the chart below.


As required to be disclosed for quarters with net income, basiccurriculum and diluted income per share foreducational delivery needs of its online and campus students regardless of geography. The Company's chief operating decision makers, its Chief Executive Officer, Chief Operating Officer and Chief Academic Officer, manage the three months ended January 31, 2017, were calculatedCompany's operations as follows:


 

 

Basic

 

 

Diluted

 

Numerator

 

 

 

 

 

 

Net income applicable to common stock

 

$

7,377

 

 

$

7,377

 

Convertible debt interest

 

 

 

 

 

4,010

 

 

 

$

7,377

 

 

$

11,387

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

11,467,345

 

 

 

11,467,345

 

Convertible debt

 

 

 

 

 

75,596

 

Warrants and options

 

 

 

 

 

1,498,029

 

 

 

 

11,467,345

 

 

 

13,040,970

 

 

 

 

 

 

 

 

 

 

Net income per share

 

$

0.00

 

 

$

0.00

 


a whole.

Recent Accounting Pronouncements


Pronouncement Not Yet Adopted

ASU 2017-01 - No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
In January 2017, the Financial Accounting Standards Board issued Accounting Standards Update No. 2017-01: "Business Combinations (Topic 805)-  to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This guidance is effective for interim and annual reporting periods beginning after December 15, 2017.  The Company will implement this guidance effective February 1, 2018.


ASU 2017-04 - In January 2017, the Financial Accounting Standards Board issued Accounting Standards Update No. 2017-04: "Intangibles - Goodwill and Other (Topic 350)” - to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill.  This guidance is effective for interim and annual reporting periods beginning after December 15, 2019.  The Company is evaluating the effects of this standard on its consolidated financial statements.  


ASU 2016-02- In FebruaryJune 2016, the Financial Accounting Standards Board ("FASB") issued Accounting StandardsStandard Update ("ASU") No. 2016-02: “Leases2016-13, Financial Instruments—Credit Losses (Topic 842)”whereby lessees326): Measurement of Credit Losses on Financial Instruments, which significantly changes how entities will need tomeasure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize almost all leasesallowances based on their balance sheet as a rightexpected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of use assetTopic 326 for certain small public companies and a lease liability.  This guidance is effective for interim and annual reporting periodsother private companies until fiscal years beginning after December 15, 2018.2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company expects this ASU will increase its assetsis currently evaluating the new guidance and liabilities, butdoes not expect the adoption of the new standard to have no neta material impact on its consolidated financial statements.




statements when adopted on the effective date of May 1, 2023.

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures. The guidance was issued as improvements to ASU No. 2016-13 described above. The
10



Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



ASU 2014-09 - In May 2014, the Financial Accounting Standards Board issued Update No. 2014-09: “Revenue from Contracts with Customers (Topic 606)” which requires that


vintage disclosure changes require an entity recognize revenue to depictdisclose current-period gross write-offs by year of origination for financing receivables. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The amendments should be applied prospectively. Early adoption of the transfer of promised goods and services to customersamendments is permitted, including adoption in an amount that reflectsinterim period. The amendments will impact our disclosures but will not otherwise impact the considerationconsolidated financial statements. The Company is currently evaluating the new guidance.
Reclassifications
Certain prior fiscal year amounts have been reclassified to which the Company expects to be entitled in exchange for those goods or services.  Since the issuance of the original standard, the FASB has issued several updatesconform to the standardcurrent year presentation.
The tenant improvement allowances received from landlord's balance of $816,591 for the nine months ended January 31, 2022, which i) clarify the applicationwas previously included in "Purchases of the principal versus agent guidance; ii) clarify the guidance relating to performance obligationsproperty and licensing;  iii) clarify assessment of the collectability criterion, presentation of sales taxes, measurement date for non-cash consideration and completed contracts at transaction; and iv) clarify narrow aspects of ASC 606 or corrects unintended application of the guidance. The new revenue recognition standard, amended by the updates, becomes effectiveequipment" in the first quarteraccompanying consolidated statements of cash flows, was reclassified to "Disbursements for reimbursable leasehold improvements" to align with the current fiscal 2019 andyear presentation. There is no impact to be applied retrospectively using onetotal cash used in investing activities included in the accompanying consolidated statements of two prescribed methods.  Early adoption is permitted.  The Company currently plans to adoptcash flows for the new standard effective May 1, 2018 and does not believe the adoption of this standard will have a material impact on the amount or timing of its revenues.

nine months ended January 31, 2022.


Note 3. Property and Equipment


As property and equipment become fully expired,reach the end of their useful lives, the fully expired asset isassets are written off against the associated accumulated depreciation.depreciation and amortization.
When assets are disposed of before reaching the end of their useful lives both the recorded cost of the fixed asset and the corresponding amount of accumulated depreciation is reversed. Any remaining difference between the two, net of proceeds, is recognized as either other income or expense. There iswas no expense impact for such write offs. Property and equipment consisted of the following at January 31, 2018 and April 30, 2017:


 

 

January 31,

 

 

April 30,

 

 

 

2018

 

 

2017

 

Call center hardware

 

$

96,305

 

 

$

53,748

 

Computer and office equipment

 

 

130,137

 

 

 

103,649

 

Furniture and fixtures

 

 

712,209

 

 

 

255,984

 

Software

 

 

2,590,297

 

 

 

2,131,344

 

 

 

 

3,528,948

 

 

 

2,544,725

 

Accumulated depreciation and amortization

 

 

(1,161,030

)

 

 

(1,090,010

)

Property and equipment, net

 

$

2,367,918

 

 

$

1,454,715

 


Software consisted of the following at January 31, 2018 and April 30, 2017:


 

 

January 31,

 

 

April 30,

 

 

 

2018

 

 

2017

 

Software

 

$

2,590,297

 

 

$

2,131,344

 

Accumulated amortization

 

 

(1,012,655

)

 

 

(994,017

)

Software, net

 

$

1,577,642

 

 

$

1,137,327

 


Depreciation and Amortization expense for all Property and Equipment as well as the portion for just software is presented below for three and nine months ended January 31, 2018 and 2017:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

January 31,

 

 

Nine Months Ended

January 31,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization Expense

 

$

150,596

 

 

$

119,064

 

 

$

407,346

 

 

$

378,118

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Software amortization Expense

 

$

121,695

 

 

$

105,914

 

 

$

341,825

 

 

$

342,938

 


The following is a schedule of estimated future amortization expense of software at January 31, 2018:


Year Ending April 30,

 

 

 

2018

 

$

127,811

 

2019

 

 

456,038

 

2020

 

 

386,196

 

2021

 

 

313,749

 

2022

 

 

293,848

 

Total

 

$

1,577,642

 



11



ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY 31, 2018

(Unaudited)



Note 4. Courseware


Courseware costs capitalized were $33,369 for the nine months ended January 31, 2018. Fully expired courseware is written off against the accumulated amortization. There is no expense impact for such write-offs.


Courseware consisted of the following at January 31, 2018 and April 30, 2017:


 

 

January 31,

 

 

April 30,

 

 

 

2018

 

 

2017

 

Courseware

 

$

283,046

 

 

$

271,777

 

Accumulated amortization

 

 

(145,489

)

 

 

(126,300

)

Courseware, net

 

$

137,557

 

 

$

145,477

 


Amortization expense of coursewarewrite-offs for the three and nine months ended January 31, 20182023 and 2017:


 

 

For the

 

 

For the

 

 

 

Three Months Ended

January 31,

 

 

Nine Months Ended

January 31,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization expense

 

$

13,966

 

 

$

13,663

 

 

$

41,289

 

 

$

44,664

 


The following is a schedule2022.

Software consisted of estimated futurethe following:
January 31, 2023April 30, 2022
Software$11,306,700 $10,285,096 
Accumulated amortization(6,596,730)(5,170,943)
Software, net$4,709,970 $5,114,153 
Depreciation and amortization expense for property and equipment and software is summarized below:
Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Depreciation and amortization expense:
Property and equipment, excluding software$417,044 $418,081 $1,281,521 $1,136,929 
Software$478,455 $443,284 $1,425,787 $1,283,088 
Note 4. Courseware and Accreditation
As courseware and accreditation reach the end of courseware attheir useful life, they are written off against the accumulated amortization. There was no expense impact for such write-offs for the three and nine months ended January 31, 2018:


Year Ending April 30,

 

 

 

2018

 

$

14,152

 

2019

 

 

56,143

 

2020

 

 

42,301

 

2021

 

 

15,336

 

2022

 

 

9,625

 

Total

 

$

137,557

 


2023 and 2022.

11

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

Courseware and accreditation consisted of the following:
January 31, 2023April 30, 2022
Courseware$657,282 $575,283 
Accreditation59,350 59,350 
716,632 634,633 
Accumulated amortization(428,608)(360,586)
Courseware and accreditation, net$288,024 $274,047 
Amortization expense for courseware and accreditation is summarized below:
Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Courseware and accreditation amortization expense$23,653 $21,744 $68,022 $58,877 
Amortization expense is included in "Depreciation and amortization" in the unaudited consolidated statements of operations.
Note 5. Senior Secured Term Loan


Debt


January 31, 2023April 30, 2022
Credit Facility due March 14, 2023 (the "2022 Revolving Credit Facility")$— $— 
Credit Facility due November 4, 2023 (the "2018 Credit Facility"); interest payable monthly in arrears5,000,000 5,000,000 
12% Convertible Notes due March 14, 2027 (the "2022 Convertible Notes"); interest payable monthly in arrears10,000,000 10,000,000 
Total long-term debt15,000,000 15,000,000 
   Less: current portion of long-term debt(5,000,000)— 
   Less: unamortized debt discount(42,672)(124,265)
Total long-term debt, net$9,957,328 $14,875,735 
2022 Convertible Notes
On July 25, 2017,March 14, 2022, the Company signed aissued $10 million seniorin principal convertible notes (the "2022 Convertible Notes") to two unaffiliated lenders (individually a "Lender" and collectively, the "Lenders") in exchange for $5 million notes to each of the two unaffiliated Lenders. The proceeds are used for general corporate purposes, including funding the Company’s previous expansion of its BSN Pre-Licensure nursing degree program. The key terms of the Convertible Notes are as follows:

At any time after issuance date, the Lenders had the right to convert the principal into shares of the Company’s common stock at a conversion price of $1.00 per share;
The Convertible Notes automatically convert at $1.00 per share into shares of the Company’s common stock if the average closing price of our common stock is at least $2.00 over a 30 consecutive trading day period. This mandatory conversion is subject to each Lender’s 9.9% beneficial ownership limitation;
The Convertible Notes are due March 14, 2027 or approximately five years from the closing;
The interest rate of the Convertible Notes was 12% per annum (payable monthly in arrears), which increased to 14% per annum on May 12, 2023. See Note 11. Subsequent Events; and
The Convertible Notes are secured by a first priority lien (which was subsequently subordinated, as disclosed in Note 11. Subsequent Events) in all current and future accounts receivable of the Company’s subsidiaries, certain of the deposit accounts of the Company and its subsidiaries and a pledge of the common stock of the Company held by its Chief Executive Officer (the “2022 Collateral”).
12

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

At closing of the 2022 Convertible Notes, the Company agreed to pay each Lender's legal fees arising from this transaction of $135,562 and another $60,833 incurred during August 2022, which has been recorded as a deferred financing cost debt discount and is being amortized over a one-year period in "Interest expense" in the accompanying consolidated financial statements.
2022 Revolving Credit Facility
On March 14, 2022, the Company entered into Revolving Promissory Note and Security Agreements (the "2022 Revolver Agreements") with the same two unaffiliated Lenders of the 2022 Convertible Notes for a one-year, $20 million secured revolving line of credit that requires monthly interest payments on sums borrowed at the rate of 12% per annum (the "2022 Revolving Credit Facility"). At January 31, 2023, there were no outstanding borrowings under the 2022 Revolving Credit Facility. The Company paid a 1% commitment fee of $200,000 at closing, which was recorded as a deferred financing cost, non-current asset, and is being amortized over the term of the loan of one-year, and another 1% commitment fee of $200,000 six months from the closing date, or September 14, 2022, since the revolving credit facility has not been replaced. On March 14, 2023, the 2022 Revolving Credit Facility expired.
Pursuant to the 2022 Convertible Notes (the "Notes"), all future indebtedness incurred by the Company, other than indebtedness expressly permitted by such Notes, will be subordinated to the Notes and the Prior Credit Facility, as defined below, with Runway Growth Capital Fund (formerly known as GSV Growth Capital Fund)an exception for acquisitions of software and equipment under purchase money agreements and capital leases.

On March 14, 2022, in connection with the issuance of the Notes, the Company also entered into an intercreditor agreement (the “Intercreditor Agreement”) among the Company, the Lenders and the lender under a prior credit facility dated November 5, 2018 (as amended, the “2018 Credit Facility”). The Intercreditor Agreement provides among other things that the Company's obligations under, and the security interests in the Collateral granted pursuant to the Notes and the 2018 Credit Facility shall rank pari passu to one another.

In connection with the issuance of the Notes, the Company drew $5 million underalso entered into an Investors/Registration Rights Agreement with the facility at closing, then subsequently drew $2.5 million followingLenders (the “Registration Rights Agreement”) whereby, upon request of either Lender on or after August 15, 2022 the Company must file and obtain and maintain the effectiveness of a registration statement registering the shares of common stock issued or issuable upon conversion of the Convertible Notes. No lender requests have been made as of the date of this filing.

On March 14, 2022, the Company entered into an amendment with the lender pursuant to the 2018 Credit Facility to extend the maturity date of the 2018 Credit Facility by one year to November 4, 2023. See the "2018 Credit Facility" discussion below.

On March 14, 2022, the Company entered into a letter agreement with the Lenders (the “Letter Agreement”). Pursuant to the Letter Agreement, the Company and its subsidiaries made certain representations and warranties to the Lenders. The Letter Agreement also contained certain conditions precedent to the closing of the Company’s acquisition of substantially alltransactions.
On April 22, 2022, the assetsCompany entered into an agreement with an insurance company (the "Insurance Company") which issued an approximately $18.3 million surety bond which was required by the Arizona State Board for Private Postsecondary Education. In order to cause the Insurance Company to deliver the surety bond, the Company entered into a First Amendment to the Intercreditor Agreement with the two Lenders of the United States University, including receipt of all required regulatory approvals, among other conditionsMarch 14, 2022, financing arrangements to funding. Termsamend the Intercreditor Agreement entered into by the same parties on March 14, 2022 (the “Amendment”). The Amendment provided that the Company and each of the 4-year senior loan include a 10% over 3-month LIBOR per annum interest rate.


TheLenders, at all times prior to the delivery of the Termination Certificate (as defined below), excluding funding as directed by the surety bond as described more fully below, (i) the Company willshall not be permitted to make any draw request or borrow any funds under the 2022 Revolver Agreements and (ii) the Lenders shall not be required to begin making principal repayments uponfund any loan or advance any funds under the 24-month anniversary2022 Revolver Agreements. Upon that certain surety bond ceasing to be outstanding, the Company shall deliver to the lenders a certificate (such certificate, the “Termination Certificate”), certifying that the surety bond is no longer outstanding and that there are no further obligations in respect of the initial closing (July 24, 2019), and each month thereafter will repay 1/24thsurety bond owing by the Company to the Insurance Company. Prior to issuance of the total loan amount outstanding.  ShouldTermination Certificate and during the time the surety bond is in effect, the Insurance Company may cause the Company achieve both annualized revenue growthto draw on funds for the express purposes of at least 30% and operating margin of at least 7.5% for any 12-month trailing period, then atresolving claims filed under the quarter-end of that 12-month trailing period,surety bond. In addition to the draw restriction on the 2022 Revolver Agreements, the Insurance Company required the Company may elect to extend the interest only periodrestrict $5 million of cash. As consideration for the quarter immediately followingLenders agreeing to enter into the 12-month trailing period throughout the duration of the loan.


Additionally,Amendment, the Company paid a 0.25% origination fee on the initial $5 million draw and paid another 0.25% origination fee upon the second $2.5 million draw, will be subjectagreed to a final payment fee of 3.25% of the principal lent, and issued 224,174 5-yearissue each Lender 100,000 five-year warrants exercisable at an exercise price of $6.87.$1.00 per share. The relative fair value of the warrants was $478,428is $118,000 and was recorded as debt discount along with other direct costsis being amortized over the remaining term of the debt. The fair value of the warrants are treated as deferred financing costs, a non-current asset, in the accompanying consolidated balance sheets at April 30, 2022. Total unamortized costs at January 31, 2023 were $29,500. See Note 6. Stockholders’ Equity for additional information related to these warrants.

13

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

On October 31, 2022, Aspen University and the Arizona State Board for Private Postsecondary Education entered into a revised stipulated agreement that reduced AU's surety bond requirement from $18.3 million to $5.5 million and required Aspen University to pay a civil penalty of $12,000.
In December 2022, as a result of the revised stipulated agreement with the Arizona State Board for Private Postsecondary Education on October 31, 2022, $1.5 million of the restricted cash associated with the surety bond became unrestricted, providing additional cash for operations.
On January 12, 2023, the Company entered into an agreement with an Insurance Company described above, the effect of which was to remove the Company’s prohibition from borrowing under the 2022 Revolving Credit Facility. As a result, the Company and certain lenders entered into a Second Amendment to the Intercreditor Agreement, which removed a provision which was added by the First Amendment restricting the Company’s ability to draw down from the 2022 Revolving Credit Facility while the Insurance Company’s surety bond remained outstanding. The 2022 Revolving Credit Facility subsequently expired.

2018 Credit Facility
On November 5, 2018, the Company entered into the 2018 Credit Facility Agreement with the Leon and Toby Cooperman Family Foundation (the “Foundation”). The Credit Facility Agreement provides for a $5,000,000 revolving credit facility (the "2018 Credit Facility") evidenced by a revolving promissory note (the “Revolving Note”). Borrowings under the 2018 Credit Facility Agreement bear interest at 12% per annum. Interest payments are due monthly through the term loanof the 2018 Credit Facility. The Revolving Note was paid on May 12, 2023, with the proceeds from the 15% Senior Secured Debentures. See Note 11. Subsequent Events.
On August 31, 2021, the Company extended the 2018 Credit Facility Agreement with the Foundation by one year from November 4, 2021, to November 4, 2022 (see below, which were extended by one year). In conjunction with the extension of the 2018 Credit Facility on August 31, 2021, the Company drew down funds of $5,000,000. At each January 31, 2023 and April 30, 2022, there were $5,000,000 outstanding borrowings under the 2018 Credit Facility.
Additionally, on August 31, 2021, the Company issued to the Foundation warrants, as an extension fee, to purchase 50,000 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $5.85 per share. The fair value of the warrants is $137,500 and is being amortized to interest expense through the maturity date of November 4, 2023, as extended on March 14, 2022. On March 14, 2022, the Company extended its existing $5 million Credit Facility by one year to November 4, 2023, at an increased interest rate from 12% to 14% per annum. The fair value of the warrants were recorded as deferred financing costs, a non-current asset, in the accompanying consolidated balance sheets at April 30, 2022, to be amortized over the term of the loan.




12


2018 Credit Facility. Total unamortized costs at January 31, 2023 were $35,065. See Note 6. Stockholders’ Equity for additional information related to these warrants.
Note 6. Stockholders’ Equity

AGI maintains two stock-based incentive plans: the 2012 Equity Incentive Plan (the “2012 Plan”) and the 2018 Equity Incentive Plan (the “2018 Plan”) that provide for the grant of shares in the form of incentive stock options, non-qualified stock options, restricted shares, stock appreciation rights and RSUs to employees, consultants, officers and directors. The 2012 Plan expired on March 15, 2022, and remains in effect for outstanding grants only, and is no longer available for new grants. On March 8, 2022, we transferred the 129,009 unused shares under the 2012 Plan to the 2018 Plan.

As of January 31, 2023 and April 30, 2022, there were 1,210,797 and 812,763 shares, respectively, remaining available for future issuance under the 2018 Plan.

On July 6, 2022, the Company amended its Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock the Company is authorized to issue from 40,000,000 to 60,000,000 authorized shares, which was approved at a special meeting of the Company's stockholders held on July 6, 2022. This increase has been retrospectively adjusted to all periods in the accompanying consolidated financial statements.

14

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



Note 6. Convertible Notes – Related Party



On December 1, 2017,22, 2021, the Company completedheld its Annual Meeting of Shareholders at which the acquisitionshareholders voted to amend the 2018 Plan to increase the number of USU and, as partshares of the consideration, a $2.0 million convertible note (the “Note”) was issued, bearing 8% annual interest that matures over a two-year period after the closing. (See Note 10) At the option of the Note holder, on each of the first and second anniversaries of the closing date, $1,000,000 of principal and accrued interestcommon stock available for issuance under the Note will2018 Plan from 1,600,000 to 2,350,000 shares.

Preferred Stock

The Company is authorized to issue 1,000,000 shares of “blank check” preferred stock with designations, rights and preferences as may be convertibledetermined from time to time by our Board of Directors. As of January 31, 2023 and April 30, 2022, we had no shares of preferred stock issued and outstanding.

Common Stock

At both January 31, 2023 and April 30, 2022, the Company was authorized to issue 60,000,000 shares of common stock, respectively.
On August 18, 2022, Aspen Group, Inc. entered into an Equity Distribution Agreement (the “Agreement”) with Northland Securities, Inc. (“Northland”), pursuant to which the Company could issue and sell from time to time, through Northland, shares of the Company’s common stock (the “Shares”), with offering proceeds of up to $3,000,000.

On October 11, 2022, the Company canceled the Agreement. The Company sold 11,840 shares under the Agreement and received net proceeds of $9,535.

On August 4, 2022, the Compensation Committee approved a 25,000 common stock grant to Lampert Capital Advisors for financial advisory services to assist with locating and securing an accounts receivable financing facility to position the Company for future growth among its online post-licensure nursing degree programs. The grant had a grant date fair value of $24,500 based on the volume weighted averagea closing stock price of $0.98 per share, for the ten preceding trading days (subject to a floor of $2.00 per share) or become payable in cash. Thereand it was no beneficial conversion featurefully vested on the note dategrant date. The expense related to this grant of $24,500 was incurred in the second quarter of fiscal 2023. The expense is included in "General and administrative" expense in the conversion termsconsolidated statements of operations. See Note 11. Subsequent Events for additional fees and expenses paid in connection with the note exempt it from derivative accounting.


Note 7. Commitments15% Senior Secured Debentures on May 12, 2023.


Restricted Stock

As of both January 31, 2023 and Contingencies


Employment Agreements


From timeApril 30, 2022, there were no unvested shares of restricted common stock outstanding. During the nine months ended January 31, 2023 and 2022, there were 10,000 and zero restricted stock expirations. There is no unrecognized compensation expense related to time, the Company enters into employment agreements with certain of its employees. These agreements typically include bonuses, some of which are performance-based in nature. Asrestricted stock as of January 31, 2023.


Restricted Stock Units
A summary of the Company’s RSU activity, granted under the 2012 and 2018 no performance bonuses have been earned.


Legal Matters


From time to time, we may be involved in litigation relating to claims arising out of our operations inEquity Incentive Plans, during the normal course of business. As ofnine months ended January 31, 2018, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results2023 is presented below:

Restricted Stock UnitsNumber of SharesWeighted Average Grant Date Fair Value
Unvested balance outstanding, April 30, 2022929,928 $6.12 
Granted15,000 0.35 
Forfeits(185,059)7.65 
Vested(236,813)0.70 
Expired— — 
Unvested balance outstanding, January 31, 2023523,056 $7.87 
___________________


15

Table of our operations.


Regulatory Matters


The Company’s subsidiaries, Aspen University and United States University, are subject to extensive regulation by Federal and State governmental agencies and accrediting bodies. In particular, the Higher Education Act (the “HEA”) and the regulations promulgated thereunder by the DOE subject the subsidiaries to significant regulatory scrutiny on the basis of numerous standards that schools must satisfy to participate in the various types of federal student financial assistance programs authorized under Title IV of the HEA.


On August 22, 2017, the DOE informed Aspen University of its determination that the institution has qualified to participate under the HEA and the Federal student financial assistance programs (Title IV, HEA programs), and set a subsequent program participation agreement reapplication date of March 31, 2021.


USU currently has provisional certification to participate in the Title IV Programs due to the business combination. The provisional certification allows the school to continue to receive Title IV funding as it did prior to the change of ownership.


The HEA requires accrediting agencies to review many aspects of an institution's operations in order to ensure that the education offered is of sufficiently high quality to achieve satisfactory outcomes and that the institution is complying with accrediting standards. Failure to demonstrate compliance with accrediting standards may result in the imposition of probation, the requirements to provide periodic reports, the loss of accreditation or other penalties if deficiencies are not remediated.


Because Aspen University and USU operate in a highly regulated industry, it may be subject from time to time to audits, investigations, claims of noncompliance or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions or common law causes of action.




13



Contents

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



Return


On August 16, 2021, the Compensation Committee approved a 125,000 RSU grant to the Company’s newly hired Chief Financial Officer as part of Title IV Funds


An institution participatinghis employment agreement. The grant has a grant date fair value of $725,000 based on a closing stock price of $5.80 per share. On August 12, 2021, the Compensation Committee approved individual grants of 80,000 RSUs to the Company’s Chief Operating Officer and Chief Academic Officer. The grants have a total grant date fair value of $1.0 million based on a closing stock price of $6.48 per share.


The three executive grants discussed above are under the Company’s 2018 Plan and are set to vest annually over a period of three years and are subject to continued employment as an officer of the Company on each applicable vesting date. The amortization expense related to these grants for the three and nine months ended January 31, 2023 was $146,817 and $440,450, respectively, which is included in Title IV Programs must correctly calculate"general and administrative expense" in the accompanying consolidated statement of operations. The amortization expense related to these grants for the three and nine months ended January 31, 2022 was $146,817 and $293,633, respectively.

On July 21, 2021, as part of a new employment agreement, the Compensation Committee approved a 125,000 RSU grant to the Company's Chief Executive Officer under the Company's 2018 Plan. The grant had a grant date fair value of $873,750 based on a closing stock price of $6.99 per share. As stipulated in the grant, vesting is subject to continued employment with the Company and will occur in full on the date the Company files with the SEC a quarterly or annual report on Forms 10-Q or 10-K, as applicable, which reflects the Company's reported net income on a GAAP basis. The Company was amortizing the expense over three years through July 2024 (the anticipated filing date of the Form 10-K for Fiscal Year 2024). At July 31, 2022, the Company assessed that the performance condition will not be met. Therefore, the cumulative amortization expense related to this grant of $242,708 was reversed, which is included in general and administrative expense in the consolidated statements of operations. The amortization expense related to this grant for the three and nine months ended January 31, 2022 was $(121,354) and $169,896, respectively, which is included in "General and administrative" expense in the consolidated statements of operations prior to the reversal.

Of the 523,056 unvested RSUs outstanding at January 31, 2023, 162,500 remain from the February 4, 2020 executive grant. These RSUs vest four years from the grant date, if each applicable executive is still employed by the Company on the vesting date, and are subject to accelerated vesting for all RSUs if the closing price of the Company’s common stock is at least $12 for 20 consecutive trading days. On the grant date, the closing price of the Company's common stock on The Nasdaq Global Market was $9.49 per share. The amortization expense related to this grant for the three and nine months ended January 31, 2023 was $91,531 and $148,911, respectively, which includes an expense reversal of $139,431 due to the resignation of the Chief Nursing Officer on July 15, 2022. The amortization expense related to these transactions for the three and nine months ended January 31, 2022, was $112,155 and $336,466, respectively. The amortization expense is included in general and administrative expense in the consolidated statements of operations. The remaining unvested RSUs during the three and nine months ended January 31, 2023 were granted to employees.

At January 31, 2023, total unrecognized compensation expense related to unvested RSUs is $1,709,599 and is expected to be recognized over a weighted-average period of approximately 1.00 years.
Warrants
The Company estimates the fair value of warrants utilizing the Black-Scholes pricing model, which is dependent upon several variables such as the expected term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected term and expected dividend yield rate over the expected term. The Company believes this valuation methodology is appropriate for estimating the fair value of warrants issued which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes expense on a straight-line basis over the vesting period of each warrant issued.
16

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

A summary of the Company’s warrant activity during the nine months ended January 31, 2023 is presented below:
WarrantsNumber of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance Outstanding, April 30, 2022649,174 $4.70 1.96$— 
Granted— $— — — 
Exercised— $— — — 
Surrendered— $— — — 
Expired(224,174)$6.87 — — 
Balance Outstanding, January 31, 2023425,000 $3.56 3.02$— 
Unvested(16,667)
Exercisable, January 31, 2023408,333 $3.42 3.00$— 

OUTSTANDING WARRANTSEXERCISABLE WARRANTS
Exercise
Price
Weighted
Average
Exercise
Price
Outstanding
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining Life
In Years
Exercisable
Number of
Warrants
$1.00 1.00 200,000 $1.00 4.23200,000 
$4.89 $4.89 50,000 $4.89 1.1950,000 
$5.85 $5.85 50,000 $5.85 3.5850,000 
$6.00 $6.00 100,000 $6.00 1.09100,000 
$6.99 $6.99 25,000 $6.99 3.478,333 
 425,000   408,333 

On April 22, 2022, as consideration for amending the Intercreditor Agreement, the Company issued warrants to the same two unaffiliated Lenders of the 2022 Convertible Notes, to each purchase 100,000 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $1.00 per share. See Note 5. Debt. The fair value of the warrants is $118,000 and is being amortized over the remaining term of the debt. The fair value of the warrants is treated as deferred financing costs, a non-current asset, in the accompanying consolidated balance sheets at January 31, 2023 and April 30, 2022. Total unamortized costs at January 31, 2023 and April 30, 2022 was $29,500 and $118,000, respectively. The Company has recognized $29,500 and $88,500 of amortization expense in connection with the fair value of the warrants for the three and nine months ended January 31, 2023, respectively, which is included in "interest expense" in the accompanying consolidated statement of operations.
On August 31, 2021, the Board of Directors approved the issuance of warrants to the Leon and Toby Cooperman Family Foundation as an extension fee in connection with the extension of the 2018 Credit Facility Agreement. The warrants allow for the purchase of 50,000 shares of the Company’s common stock and have an exercise price of $5.85. The warrants have an exercise period of five years from the August 31, 2021 issuance date and will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $137,500 and is being amortized over the 14-month line of credit period. The Company has recognized $11,168 and $33,504 of amortization expense in connection with the fair value of the warrants for the three and nine months ended January 31, 2023, respectively, which is included in "interest expense" in the accompanying consolidated statement of operations.

On July 21, 2021, the Executive Committee approved the issuance of warrants to a former member of the Board of Directors for the purchase of 25,000 shares of the Company's common stock with an exercise price of $6.99 per share. The warrants have an exercise period of five years from the July 21, 2021 issuance date and vest annually over a three-year period subject to continued service on the Company's Advisory Board on each applicable vesting date. The warrants will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $84,000 and is being amortized
17

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

over the three-year vesting period. The Company has recognized $7,000 and $21,000 of amortization expense in connection with the fair value of the warrants for the three and nine months ended January 31, 2023, respectively, which is included in general and administrative expense in the accompanying consolidated statement of operations.
Stock Option Grants to Employees and Directors

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.

There were no options granted to employees during the nine months ended January 31, 2023 and 2022.

A summary of the Company’s stock option activity for employees and directors during the nine months ended January 31, 2023, is presented below:
OptionsNumber of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance Outstanding, April 30, 2022860,182 $7.03 1.25$— 
Granted— — — — 
Exercised— — — — 
Forfeited(36,634)8.89 — — 
Expired(209,090)7.42 — — 
Balance Outstanding, January 31, 2023614,458 $6.79 0.73$— 
Exercisable, January 31, 2023614,458 $6.79 0.73$— 


OUTSTANDING OPTIONSEXERCISABLE OPTIONS
Exercise
Price
Weighted
Average
Exercise
Price
Outstanding
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining Life
In Years
Exercisable
Number of
Options
$3.24 to $4.38$4.00 31,665 $4.00 1.5031,665 
$4.50 to $5.20$4.97 119,876 $4.97 1.03119,876 
$7.17 to $7.55$7.45 462,917 $7.45 0.60462,917 
614,458 614,458 
As of January 31, 2023, there are no unrecognized compensation costs related to unvested stock options.

18

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

Stock-based compensation related to RSUs, restricted stock and stock options

A summary of the Company’s stock-based compensation expense, which is included in "general and administrative" expense in the consolidated statement of operations is presented below:


Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
RSUs$394,510 $397,241 $893,769 $1,532,147 
Restricted Stock— 286,231 — 307,283 
Stock options— 17,225 5,407 126,137 
Total stock-based compensation expense$394,510 $700,697 $899,176 $1,965,567 

Treasury Stock

As of both January 31, 2023 and April 30, 2022, 155,486 shares of common stock were held in treasury representing shares of common stock surrendered upon the exercise of stock options in payment of the exercise prices and the taxes and similar amounts due arising from the option exercises. The values aggregating $1,817,414 were based upon the fair market value of shares surrendered as of the date of each applicable exercise date.
Note 7. Revenue

Revenue consists primarily of tuition and fees derived from courses taught by the Company online as well as from related educational resources that the Company provides to its students, such as access to its online materials and learning management system. The Company’s educational programs have starting and ending dates that differ from its fiscal quarters. Therefore, at the end of each fiscal quarter, a portion of revenue from these programs is not yet earned and is therefore deferred. The Company also charges students fees for library and technology costs, which are recognized over the related service period and are not considered separate performance obligations. Other services, books, and exam fees are recognized as services are provided or when goods are received by the student. The Company’s contract liabilities are reported as deferred revenue and due to students. Deferred revenue represents the amount of unearnedtuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets.
The following table represents the Company's revenue disaggregated by the nature and timing of services:
Three Months Ended January 31,Nine Months Ended January 31,
 2023202220232022
Tuition - recognized over period of instruction
$13,301,292 $16,550,586 $44,264,750 $50,304,380 
Course fees - recognized over period of instruction
1,745,950 1,981,470 5,760,009 5,967,581 
Book fees - recognized at a point in time
— — — 42,777 
Exam fees - recognized at a point in time
219,869 199,924 690,395 590,337 
Service fees - recognized at a point in time
306,931 212,818 827,348 410,929 
Revenue$15,574,042 $18,944,798 $51,542,502 $57,316,004 
Contract Balances and Performance Obligations
The Company recognizes deferred revenue as a student participates in a course which continues past the consolidated balance sheet date.
The deferred revenue balance as of January 31, 2023 and April 30, 2022, was $8,075,063 and $5,889,911, respectively. During the nine months ended January 31, 2023, the Company recognized $5,122,057 of revenue that was included in the deferred revenue balance as of April 30, 2022. The Company classifies deferred revenue as current since the remaining term of the course, including the affect to the refund policy, is one year or less. There is no long-term deferred revenue.
19

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

When the Company begins providing the performance obligation by beginning instruction in a course, a contractual receivable is created, resulting in accounts receivable. The Company accounts for receivables in accordance with ASC 310, Receivables. The Company uses the portfolio approach.
Cash Receipts
The Company's students finance costs through a variety of funding sources, including, among others, monthly payment plans, installment plans, federal loan and grant programs (Title IV), employer reimbursement, and various veteran and military funding and grants, and cash payments. Most students elect to use our monthly payment plan. This plan allows them to make fixed monthly payments over the length of the payment plan. Title IV Program fundsand military funding typically arrive during the period of instruction. Students who receive reimbursement from employers typically do so after completion of a course. Students who choose to pay cash for a class typically do so before beginning the class.
Significant Judgment
We analyze revenue recognition on a portfolio approach under ASC 606-10-10-4. Significant judgment is utilized in determining the appropriate portfolios to assess for meeting the criteria to recognize revenue under ASC Topic 606. We have determined that have been disbursedall of our students can be grouped into one portfolio. Students behave similarly, regardless of their payment method. Enrollment agreements and refund policies are similar for all of our students. We do not expect that revenue earned for the portfolio is significantly different as compared to revenue that would be earned if we were to assess each student contract separately.
The Company maintains institutional tuition refund policies, which provides for all or a portion of tuition to be refunded if a student withdraws during stated refund periods. Certain states in which students who withdraw from their educational programs before completion and must return those unearned fundsreside impose separate, mandatory refund policies, which override the Company’s policy to the extent in conflict. If a timely manner, no later than 45 daysstudent withdraws at a time when a portion or none of the datetuition is refundable, then in accordance with its revenue recognition policy, the schoolCompany recognizes as revenue the tuition that was not refunded. Since the Company recognizes revenue pro-rata over the term of the course and because, under its institutional refund policy, the amount subject to refund is never greater than the amount of the revenue that has been deferred, under the Company’s accounting policies revenue is not recognized with respect to amounts that could potentially be refunded.
The Company had revenue from students outside the United States totaling approximately 2% of consolidated revenue for each of the three and nine months ended January 31, 2023 and 2022, respectively.
Teach-out of the Pre-licensure Nursing Program
On September 20, 2022, Aspen University and the Arizona State Board of Nursing entered into a Consent Agreement under which Aspen agreed to voluntarily surrender its program approval for its pre-licensure nursing program in Phoenix. Having entered into this agreement, the Company also determined to voluntarily suspend new enrollments to its pre-licensure nursing program in Florida, Georgia, Tennessee and Texas, and will complete instruction for currently enrolled Core nursing students in these locations. The state authorizing units and state boards of nursing were given notice to this effect on September 20, 2022.

For the three and nine months ended January 31, 2023, 19% and 22% of total consolidated AGI revenue was earned from its pre-licensure nursing program. For the three and nine months ended January 31, 2022, 24% and 23% of total consolidated AGI revenue was earned from this program.
Note 8. Leases
The Company determines if a contract contains a lease at inception. The Company entered into operating leases totaling approximately 172,021 square feet of office and classroom space in Phoenix, San Diego, New York City, Denver, Austin, Tampa, Nashville, Atlanta and the New Brunswick Province in Canada. These leases expire at various dates through April 2031, and the majority contain annual base rent escalation clauses. Most of these leases include options to extend for additional five-year periods. Since it is not reasonably certain that the student has withdrawn. Under Department regulations, failureleases would be renewed, the Company does not consider the renewal option in the lease term. As permitted by ASC 842, leases with an initial term of twelve months or less are not recorded on the accompanying consolidated balance sheet. The Company does not have any financing leases.

20

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

As of January 31, 2023, our longer-term operating leases are located in Tampa, Phoenix, Austin, Nashville and Georgia and are set to expire in six to eight years. These leases make up approximately 95% of the total future minimum lease payments.
Operating lease ROU assets, represent the right to use an underlying asset for the lease term. Operating lease liabilities represent the obligation to make timely returns of Title IV Program funds for 5% or more of students sampledlease payments arising from the lease. Operating leases are included in "Operating lease right- of-use assets, net", "Operating lease obligations, current portion" and "Operating lease obligations, less current portion" in the consolidated balance sheets at January 31, 2023 and April 30, 2022. These assets and lease liabilities are recognized based on the institution's annual compliance auditpresent value of remaining lease payments over the lease term. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. When the lease does not provide an implicit interest rate, the Company uses an incremental borrowing rate of 12% to determine the present value of the lease payments.
Lease incentives are deducted from the ROU assets. Incentives such as tenant improvement allowances are amortized as leasehold improvements, separately, over the life of the lease term. For the three and nine months ended January 31, 2023, the amortization expense for these leasehold improvements was $171,133 and $530,076, respectively. For the three and nine months ended January 31, 2022, the amortization expense for these leasehold improvements was $177,259 and $483,872, respectively.
Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense for the three and nine months ended January 31, 2023 was $1,002,215 and $3,093,914, respectively, which is included in either of its two most recently completed fiscal years can resultgeneral and administrative expenses in the institution having to post a letterconsolidated statements of credit in an amount equal to 25% of its required Title IV returns during its most recently completed fiscal year. If unearned fundsoperations. Lease expense for the three and nine months ended January 31, 2022 was $1,008,704 and $2,861,876, respectively.
ROU assets are not properly calculated and returned in a timely manner, an institution is also subject to monetary liabilities or an action to impose a fine or to limit, suspend or terminate its participation in Title IV Programs.


Subsequent to a compliance audit, USU recognized that it had not fully complied with all requirements for calculating and making timely returns of Title IV funds (R2T4).  In 2016, USU had a material findingsummarized below:
January 31, 2023April 30, 2022
ROU assets - Operating facility leases$18,548,616 $15,958,721 
Less: accumulated amortization(4,682,744)(3,312,771)
Total ROU assets$13,865,872 $12,645,950 


Operating lease obligations, related to the same issueROU assets are summarized below:
January 31, 2023April 30, 2022
Total lease liabilities$25,634,092 $22,517,355 
Reduction of lease liabilities(5,417,572)(3,671,466)
Total operating lease obligations$20,216,520 $18,845,889 
The following is a schedule by future minimum lease payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year as of January 31, 2023 (by fiscal year).
Maturity of Lease ObligationsLease Payments
2023 (remaining)$1,151,111 
20244,739,252 
20254,547,151 
20264,677,144 
20274,782,909 
Thereafter9,727,292 
Total future minimum lease payments29,624,859 
    Less: imputed interest(9,408,339)
Present value of operating lease liabilities$20,216,520 

21

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

Balance Sheet ClassificationJanuary 31, 2023April 30, 2022
Operating lease obligations, current portion$2,346,766 $2,036,570 
Operating lease obligations, less current portion17,869,754 16,809,319 
Total operating lease obligations$20,216,520 $18,845,889 

Other InformationJanuary 31, 2023April 30, 2022
Weighted average remaining lease term (in years)6.26.8
Weighted average discount rate12 %12 %

Note 9. Income Taxes
The Company determined that it has a permanent establishment in Canada, as defined by article V(2)(c) of the Convention between Canada and is requiredthe United States of America with Respect to maintainTaxes on Income and on Capital (the “Treaty”), which would be subject to Canadian taxation as levied under the Income Tax Act. The Company filed Canadian T2 Corporation Income Tax Returns and related information returns under the Voluntary Disclosure Program with the Canada Revenue Agency ("CRA") to cover the 2013 through 2021 tax years during which a letterpermanent establishment was in place. The Company will also file an annual Canadian T2 Corporation Income Tax return to report the ongoing activity of creditthe permanent establishment for 2022 through 2023, and future taxation years.
For the three and nine months ended January 31, 2023, the Company recorded a reserve of approximately $25,000 and $75,000, respectively, for the 2023 tax year to the related foreign income tax liability. For the three and nine months ended January 31, 2022, the Company recorded a reserve of approximately $227,000 and $375,000, respectively, related to the foreign income tax liability. These reserves are included in "Accrued expenses" in the amountconsolidated balance sheets.
For the nine months ended January 31, 2022, approximately $300,000 of $71,634 as a result of this finding.  The letter of credit has been providedthe reserve relates to the Departmentestimate of Education by AGI.


Delaware Approvalthe Canada foreign income tax liability which covers the 2013 through 2021 tax years during which a permanent establishment was in place in Canada. This amount has not yet been remitted to Confer Degrees


Aspen University is a Delaware corporation. Delaware law requires an institution to obtain approval from the Delaware Department of Education (“Delaware DOE”) before it may incorporate with the power to confer degrees. In July 2012, Aspen received notice from the Delaware DOE that it was granted provisional approval status effective until June 30, 2015. On April 25, 2016 the Delaware DOE informed Aspen University it was granted full approval to operate with degree-granting authority in the State of Delaware until July 1, 2020. Aspen University is authorized by the Colorado Commission on Education to operate in Colorado as a degree granting institution.


USU is also a Delaware corporation and is in the process of obtaining Delaware approval.

CRA.


Note 10. Commitments and Contingencies
Operating Leases
The Company leases space for its campus and corporate operations. (See Note 8. Stockholders’ Equity


Common Stock


Effective May 24, 2017,Leases)


Employment Agreements
From time to time, the Company enteredenters into waiveremployment agreements with allcertain of its investorsemployees. These agreements typically include bonuses, some of which may or may not be performance-based in nature.
Legal Matters
From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the April 2017 common stock offering. In consideration for waiving their registration rights, the Company paid to eachnormal course of business. As of the investors 1.5%date of their investment amountthis Report, except as discussed below, we are not aware of any other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations, and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.
On April 6, 2022, Aspen University was served with a class action claim in Arizona Superior Court, alleging violations of the offering. The total amount paid was $112,500Arizona Consumer Fraud Act and was recorded in general and administrative expenses during the quarter ended July 31, 2017.


In November 2017, the company issued 5,000 restricted shares each to two consultants assisting with establishing the new campus. The shares were valued at $88,700Unjust Enrichment, based on the trading priceclass representative’s claims that Aspen University misstated the quality of $8.87 onits pre-licensure nursing program. This complaint was likely in response to the grant date and recordedArizona State Board of Nursing actions against Aspen University relating to the program, as a prepaid asset being amortized overoutlined below. At this time, the six month termonly action taken by

22

Table of the agreement. (See Note 11)


On December 1, 2017 certain assets were acquired and certain liabilities assumed from Educacion Significativa, LLC (dba United States University) by United States University, Inc. United States University, Inc. is a wholly owned subsidiary of Aspen Group Inc. As part of the purchase price the company issued 1,203,209 shares of AGI stock were valued at the quoted closing price of $8.49 per share as of November 30, 2017. (See Note 10)




14



Contents

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



Warrants


A summary


Aspen University was to file for change of venue which was granted. Aspen University anticipates the completion of a scheduled mediation meeting by the end of June 2023. The size of the Company’s warrant activity duringpotential class action claim is not yet known.
On February 11, 2013, HEMG, and its Chairman, Mr. Patrick Spada, sued the nine months ended January 31, 2017 is presented below:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

Warrants

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Balance outstanding, April 30, 2017

 

 

914,123

 

 

$

2.82

 

 

 

1.6

 

 

$

1,100,203

 

Granted

 

 

224,174

 

 

 

6.87

 

 

 

5.0

 

 

 

307,118

 

Exercised

 

 

(356,267

)

 

 

0.55

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(38,257

)

 

 

 

 

 

 

 

 

 

Balance outstanding, January 31, 2018

 

 

743,773

 

 

$

4.08

 

 

 

2.1

 

 

$

3,095,502

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, January 31, 2018

 

 

743,773

 

 

$

4.08

 

 

 

2.1

 

 

$

3,095,502

 


In connectionCompany, certain senior management members and our directors in state court in New York seeking damages arising principally from (i) allegedly false and misleading statements in the filings with the Senior Secured Term Loan that was finalized on July 25, 2017,SEC and the DOE where the Company issued 224,174 5-year warrants atdisclosed that HEMG and Mr. Spada borrowed $2.2 million without board authority, (ii) the alleged breach of an exercise price of $6.87. (See Note 5)


TheApril 2012 agreement whereby the Company issued 241,514had agreed, subject to numerous conditions and time limitations, to purchase certain shares of Common Stock in conjunction with the cash and cashless exercise of 356,267 warrants. The Company received $143,489 in conjunction with the cash exercises.


Stock Incentive Plan and Stock Option Grants to Employees and Directors


On March 13, 2012, the Company adoptedfrom HEMG, and (iii) alleged diminution to the 2012 Equity Incentive Plan (the “Plan”) that provides forvalue of HEMG’s shares of the grantCompany due to Mr. Spada’s disagreement with certain business transactions the Company engaged in, all with Board approval.

On December 10, 2013, the Company filed a series of 1,691,667 shares effective November 2015, 2,108,333 shares effective June 2016counterclaims against HEMG and 3,500,000 shares effective July 2017,Mr. Spada in the formsame state court of incentive stock options, non-qualified stock options, restricted shares, stock appreciation rightsNew York. By order dated August 4, 2014, the New York court denied HEMG and restricted stock unitsSpada’s motion to employees, consultants, officersdismiss the fraud counterclaim the Company asserted against them.
In November 2014, the Company and directors. AsAspen University sued HEMG seeking to recover sums due under two 2008 Agreements where Aspen University sold course materials to HEMG in exchange for long-term future payments. On September 29, 2015, the Company and Aspen University obtained a default judgment in the amount of January 31, 2018, there were 622,454 shares remaining under$772,793. This default judgment precipitated the Plan for future issuance. Thebankruptcy petition discussed in the next paragraph.
On July 21, 2021, the bankruptcy trustee paid the Company estimates$498,120 based on assets available in the fair value of share-based compensation utilizing the Black-Scholes option pricing model,trust, which is dependent upon several variables suchincluded in "other income (expense), net" in the accompanying consolidated statements of operations. As a result, the Company wrote off the net receivable of $45,329 against the payment received as settlement in the expected option term, expected volatilityfirst quarter of fiscal year 2022 and recognized a gain. No further assets are available for distribution.
On September 13, 2022, Spada, the remaining plaintiff, and AGI entered into a Stipulation Discontinuing Action under which the complaint and counterclaims were dismissed with prejudice.

Regulatory Matters
The Company’s stock price over the expected term, expected risk-free interest rate over the expected option term, expected dividend yield rate over the expected option term,subsidiaries, Aspen University and an estimate of expected forfeiture rates. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors whichUnited States University, are subject to ASC Topic 718 requirements. These amountsextensive regulation by Federal and State governmental agencies and accrediting bodies. In particular, the HEA and the regulations promulgated thereunder by the DOE subject the subsidiaries to significant regulatory scrutiny on the basis of numerous standards that schools must satisfy to participate in the various types of federal student financial assistance programs authorized under Title IV of the HEA.
Aspen UniversityRegulatory Matters
On August 22, 2017, the DOE informed Aspen University of its determination that the institution had qualified to participate under the HEA and the Federal student financial assistance programs (Title IV, HEA programs) and set a subsequent program participation agreement reapplication date of March 31, 2021. On April 16, 2021, the DOE granted provisional certification for a two-year timeframe, and set a subsequent program participation reapplication date of September 30, 2023.
The HEA requires accrediting agencies to review many aspects of an institution's operations in order to ensure that the education offered is of sufficiently high quality to achieve satisfactory outcomes and that the institution is complying with accrediting standards. Failure to demonstrate compliance with accrediting standards may result in the imposition of probation, the requirements to provide periodic reports, the loss of accreditation or other penalties if deficiencies are estimates and thusnot remediated.
Because our subsidiaries operate in a highly regulated industry, each may not be reflectivesubject from time to time to audits, investigations, claims of actual future results, nor amounts ultimately realizednoncompliance or lawsuits by recipientsgovernmental agencies or third parties, which allege statutory violations, regulatory infractions or common law causes of these grants. action.
The Company recognizes compensation on a straight-line basis over the requisite service period for each award. The following table summarizes the assumptionsis also subject to regulation by self-regulatory bodies such as accreditors and by state regulators in certain states including states where the Company utilizedhas a physical presence. Aspen University’s first-time pass rates for our BSN pre-licensure students taking the NCLEX-RN test in Arizona fell from 80% in 2020 to record compensation expense for stock options granted to employees during58% in 2021, which is below the nine months ended January 31, 2018.


January 31,

2018

Expected life (years)

4-6.5

Expected volatility

40-43

%

Risk-free interest rate

0.00

%

Dividend yield

n/a


The Company utilizedminimum 80% standard set by the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on the averageArizona State Board of Nursing (“AZ BON”). As a result of the expected volatilities from the most recent audited financial statements available for comparative public companies that are deemed to be similardecline in nature to the Company. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected lifeNCLEX pass rates and other

23

Table of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.




15



Contents

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



A summary


issues, and in alignment with a recommendation from the Arizona State Board of Nursing, the university voluntarily suspended BSN pre-licensure enrollments and the formation of new cohorts at its two Phoenix pre-licensure locations, effective February 2022. In March 2022, Aspen University entered into a Consent Agreement for Probation and a Civil Penalty (the “Consent Agreement”) with the Arizona State Board of Nursing in which Aspen University’s Provisional Approval was revoked, with the revocation stayed pending Aspen University’s compliance with the terms and conditions of the Company’s stock option activityConsent Agreement. The probationary period is 36 months from the date of the Consent Agreement. In June 2022, the AZ BON granted approval of Aspen University’s request for employeesprovisional approval as long as the program is in compliance with the consent agreement through March 31, 2025. The stay was broken into two phases, the first lasting through the end of Calendar Year 2022. During Phase I, Aspen University was not permitted to enroll any new students into the core component of its pre-licensure nursing program in Arizona and directors duringmust achieve the nine months ended January 31, 2018, is presented below:


 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

Options

 

Shares

 

 

Price

 

 

Term

 

 

Value

 

Balance outstanding, April 30, 2017

 

 

2,097,384

 

 

$

1.86

 

 

 

2.7

 

 

$

12,489,871

 

Granted

 

 

844,000

 

 

$

3.53

 

 

 

3.4

 

 

 

1,867,740

 

Exercised

 

 

(63,838

)

 

$

3.13

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding, January 31, 2018

 

 

2,877,546

 

 

$

3.52

 

 

 

3.24

 

 

$

17,658,268

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, January 31, 2018

 

 

1,083,484

 

 

$

2.22

 

 

 

2.07

 

 

$

8,727,757

 


On May 13, 2017,AZ BON-required 80% NCLEX pass rate for the Calendar Year 2022 annual reporting cycle. If this benchmark was not achieved, the AZ BON could lift the stay and initiate the revocation. If Phase I was completed successfully, Phase II will commence with Aspen University on Probation (regular or “stayed revocation” probation, depending on the outcome of Phase I). Aspen University was permitted to begin enrollments into the core component of its pre-licensure nursing program in Arizona once four consecutive quarters of 80% NCLEX first-time pass rates occur. However, once achieved, if the NCLEX pass rate fell below 80% for any quarter, the AZ BON could limit enrollments, and repeated failures may result in a required cessation of enrollments and teach-out of the program. The terms of the Consent Agreement also include requirements that the Company grantedprovide the AZ BON with monthly reports, provide that our faculty and administrators undergo additional training, retain an approved consultant to prepare and submit evaluations to the AZ BON, and hire a minimum of 35% full-time qualified faculty by September 30, 2022.

On September 20, 2022, Aspen University and the Arizona State Board of Nursing entered into a revised Consent Agreement under which Aspen agreed to voluntarily surrender its executive officersprogram approval for its pre-licensure nursing program in Phoenix, Arizona. Aspen sought the agreement after concluding that it was unable to meet the minimum 80% NCLEX first-time pass rates for calendar year 2022, which was a totalrequirement of 500,000 five-year optionsan earlier consent agreement that Aspen and the Board signed in March 2022. Aspen did so to purchase sharesminimize uncertainty for its students. Aspen had suspended admissions to its Arizona program in January 2022. For the calendar quarters ended March 31, 2022, June 30, 2022 and September 30, 2022, Aspen University's NCLEX-RN test pass rates were 73.33%, 69.64% and 59.15%, respectively.
Under the terms of the Company’s common stock underrevised Consent Agreement, many of the Plan.previous requirements were eliminated; for example, Aspen no longer has a requirement to use a consultant nor the requirement for a certain percentage of full-time faculty. However, Aspen will continue its current Arizona Core nursing program for all current students and provide regular reports to the Board of Nursing about the program. It remains accountable to the Board to ensure that its current students receive expected instruction and learning opportunities. Once all currently enrolled students in the program have either completed the program or ceased enrollment, or within two years, whichever is sooner, Aspen’s program approval will be automatically voluntarily surrendered for a minimum period of two years. As expected, although the rate improved from the 2021 rate of 58%, Aspen’s 2022 annual NCLEX-RN first-time pass rate did not meet the Arizona State Board of Nursing’s required pass rate in 2022 at 63.7%.

Having entered into the revised Consent Agreement with the Arizona State Board of Nursing, Aspen suspended new enrollments to its pre-licensure nursing program in Florida, Georgia, Tennessee and Texas and will complete instruction for currently enrolled Core nursing students in those states. The options vest annually over three years, subjectstate authorizing units and state boards of nursing were noticed to continued employmentthis effect on September 20, 2022.

On February 23, 2023, the Arizona State Board of Nursing informed Aspen of its intent to lift the stay of voluntary surrender at each applicable vesting date,its scheduled March 2023 meeting. Board members expressed concerns regarding public safety and are exercisablestudent safeness to practice on exit from the program, including concerns that the program was failing to provide minimum instruction as students were continuing to struggle with passing their NCLEX-RN exam the first time, failing to meet basic standards of educational practice by inadequately ensuring the integrity and proctoring of exams, and improperly using students' work hours to count as clinical hours and counting clinical hours when the students were not in the facilities. Aspen disputed all of these concerns except the one related to the NCLEX-RN first-time pass rate.

It was Aspen’s position that a decision by the Board to conduct such a vote to lift the stay at $4.90 per share.its scheduled March 2023 meeting would be a breach of the September 2022 Consent Agreement, a breach of the covenant of good faith and fair dealing, and cause Aspen irreparable harm. The Chairmanlifting of the stay would have closed the program immediately and Chief Executive Officer received 200,000 options with a fair value of $282,000, the Chief Operating Officer received 200,000 options with a fair value of $282,000, the Chief Academic Officer received 70,000 options with a fair value of $98,700affected almost 400 students across four states. On March 23, 2023, Aspen University and the Chief Financial Officer received 30,000 options with a fair valueArizona State Board of $42,300.


In May 2017, the Company issued 5,500 stock options to various employees at exercise prices ranging from $4.95 to $5.10 per share.


Effective June 11, 2017, the Company granted the Chief Academic Officer 30,000 five-year options. The options vest quarterly over a three-year period in 12 equal quarterly increments with the first vesting date being September 11, 2017, subject to continued employment on each applicable vesting date. The options are exercisable at $6.28 per share and the fair value is $54,000.


On August 21, 2017, 53,000 options were issued to 26 employees withNursing signed an exercise price of $5.95 per share and a fair value of $90,630.


On January 4, 2018, 180,000 options were issuedAmendment to the boardSeptember 2022 Consent Agreement that permits the teach-out of directorsthe program to continue with an exercise priceheightened

24

Table of $9.07 per share and a fair value of $421,200.


On January 14, 2018, 75,500 options were issued to employees with an exercise price of $8.57 per share and a fair value of $152,510.


During the nine months ended January 31, 2018, the company issued 113,597 shares of common stock in conjunction with the exercise of 63,838 stock options. The company received $455,387 related to these exercises.


As of January 31, 2018, there was $1,474,855 of unrecognized compensation costs related to nonvested share-based compensation arrangements. That cost is expected to be recognized over a weighted-average period of 2.0 years.


The Company recorded compensation expense of $466,468 and $253,833 for the nine months ended January 31, 2018 and 2017, respectively, in connection with stock options.


Note 9. Related Party Transactions


See Note 6 for discussion of convertible notes payable to a related party.




16



Contents

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



Note


oversight and reporting. The University will hire a Consultant and additionally an Ombudsperson to oversee critical aspects of the program in Arizona including testing and clinical practices. The signed Amendment means that the Arizona-based students are permitted to be taught out through January 2024, Nashville-based students through May 2024, and Texas- and Florida-based students through September 2024.
On March 8, 2022, Aspen University has also entered into a Stipulated Agreement with the Arizona State Board for Private Postsecondary Education which required the University to post a surety bond for $18.3 million in the fourth quarter of fiscal year 2022. The Stipulated Agreement required the cessation of enrollment in both the pre-professional nursing and core components of the program in Arizona, the submission of student records monthly, the removal of Arizona start date information from websites and catalogs, and monthly reporting to the Board staff. The collateral for this surety bond of $5 million was included in "Restricted cash" in the consolidated balance sheet at April 30, 2022. On October 31, 2022, Aspen and the Arizona State Board for Private Postsecondary Education entered into a revised 2nd Stipulated Agreement that reduces AU's surety bond requirement from $18.3 million to $5.5 million, requires a civil penalty of $12,000 and enrollment stoppage and teach out of the pre-licensure program. Other requirements from the April 2022 Stipulated Agreement were carried forward to this revised agreement. In December 2022, as a result of the revised stipulated agreement with the Arizona State Board for Private Postsecondary Education, $1.5 million of the restricted cash associated with the surety bond became unrestricted, providing additional cash for operations.
Aspen University’s State Authorization Reciprocity Agreement ("SARA"), which is overseen by a National Council ("NC-SARA"), annual approval through the Colorado SARA State Portal Entity has to be renewed by January 30 each year. Aspen University applied on January 18, 2022, and received its 2022 approval effective February 8, 2022. On February 23, 2022, Aspen University received a Notification of Provisional SARA Status from the Colorado SARA State Portal Entity. On March 4, 2022, the DOE provided the final approval for Aspen University’s move from Colorado to Arizona. On March 29, 2022, Aspen University received a Notification of Loss of Eligibility for SARA through Colorado which permitted continued SARA coverage for students enrolled for courses between February 1, 2022 and August 2, 2022. On April 10, – Acquisition2022, Aspen University submitted an official appeal of USU


the eligibility loss to the Colorado SARA State Portal Entity. Aspen University sought a return to the prior provisional status while the appeal was pending or until the completion of the existing SARA term to February 2023 or until there was approval by the Arizona SARA Council. On December 1, 2017 certain assetsApril 12, 2022, Aspen University was restored to Provisional Status by the Colorado SARA State Portal Entity according to the terms of the February 23, 2022 letter. On May 17, 2022, Aspen University was informed that its appeal was denied and on June 10, 2022, Aspen University received a letter from the Colorado SARA State Portal Entry indicating that students currently enrolled in academic terms in progress as of May 17, 2022, were acquiredcovered under SARA for 16 weeks, until September 6, 2022.

In the meantime, Aspen University submitted an application to the Arizona State SARA Portal Entry. This application to obtain approval to become an institutional participant again in NC-SARA from its new primary location in Arizona was deferred at the September 8, 2022 and certain liabilities assumed from Educacion Significativa, LLC (dba United States University) by United StatesJanuary 19, 2023 meetings, and may again be considered at the September 2023 meeting. Since February 2022, the start of the regulatory concerns over SARA approval, Aspen University Inc. United Stateshas been seeking individual state authorizations for its students. Aspen University Inc.has succeeded in securing full approval, exemption, or has determined approval is a wholly owned subsidiarynot required, in 43 states, while 5 additional states allow our currently enrolled students to continue while applications are under review or in process. Students in these states represent over 99% of the current student body.
Aspen Group Inc. (“AGI”) and was set up for purposes of finalizing the asset purchase transaction.  For purposes of purchase accounting, Aspen Group, Inc. is referred to as the acquirer. Aspen Group, Inc. acquired the assets and assumed the liabilities of Educacion Significativa, LLC (dba United States University) for a purchase price of approximately $14.8 million. The purchase consideration consisted of a cash payment of $2,500,000 less an adjustment for working capital of approximately $110,000 plus approximately $200,000 of additional costs paid to/on behalf of andbelieves it has options for the benefitfew students in Rhode Island and the District of Columbia but has determined that it will not be able to secure authorization in Maryland. Articulation agreements for students in these two states and the District of Columbia are available for the students who choose not to wait for Aspen University to obtain NC-SARA approval through Arizona.
DOE Program Review
On January 6, 2023, Aspen University received notice from the Department of Education, Office of the seller, a convertible note of $2,000,000Multi-Regional and 1,203,209 shares of AGI stock valued atForeign Schools Participation Division, that an off-site Program Review would begin on February 13, 2023. The review is designed to assess the quoted closing price of $8.49 per share as of November 30, 2017. The stock consideration represents $10,215,244University’s administration of the purchase consideration.


Title IV, HEA programs in which it participates, covering the 2021-2022 and 2022-2023 award years. The acquisition was accounted for by AGIUniversity is cooperating fully in accordance with the acquisition method of accounting pursuant to ASC 805 “Business Combinations” and pushdown accounting was applied to recordreview. Required university administrators from the fair valueoffices of the assets acquiredpresident, provost, financial aid, finance, enrollment, registrar, institutional research, and liabilities assumed on United States University, Inc. Under this method, the purchase price is allocatedstudent accounts have participated in requested meetings. They have provided requested documentation in a timely manner in a variety of areas, especially related to the identifiable assets acquired and liabilities assumed based on their estimated fair values at the dateBachelor of acquisition.Science in Nursing (Pre-Licensure) degree program. The excessreview is ongoing.

25

Table of the amount paid over the estimated fair values of the identifiable net assets was $5,011,432 which has been reflected in the balance sheet as goodwill.


The following is a summary of the estimated fair value of the assets acquired and liabilities assumed at the date of acquisition:


 

 

Purchase Price Allocation

 

 

Useful Life

 

Cash and cash equivalents

 

$

 

 

 

 

Current assets acquired

 

 

244,465

 

 

 

 

 

Other assets acquired

 

 

176,667

 

 

 

 

 

Intangible assets

 

 

 

 

 

 

 

 

Accreditation and regulatory approvals

 

 

6,200,000

 

 

 

 

 

Trade name and trademarks

 

 

1,700,000

 

 

 

 

 

Student relationships

 

 

2,000,000

 

 

2 years

 

Curriculum

 

 

200,000

 

 

1 year

 

Goodwill

 

 

5,011,432

 

 

 

 

 

Less: Current liabilities assumed

 

 

(727,601

)

 

 

 

 

Total purchase price

 

$

14,804,963

 

 

 

 

 


We determined the fair value of assets acquired and liabilities assumed based on assumptions that reasonable market participants would use while employing the concept of highest and best use of the respective items. We used the following assumptions, the majority of which include significant unobservable inputs (Level 3), and valuation methodologies to determine fair value:


·

Intangibles - We used the multiple period excess earnings method to value the Accreditation and regulatory approvals. The Trade name and trademarks were valued using the relief-from-royalty method, which represents the benefit of owning these intangible assets rather than paying royalties for their use. The Student relationships were valued using the excess earnings method.  The curriculum was valued using the replacement cost approach.

·

Other assets and liabilities - The carrying value of all other assets and liabilities approximated fair value at the time of acquisition.


The goodwill resulting from the acquisition may become deductible for tax purposes in the future.  The goodwill resulting from the acquisition is principally attributable to the future earnings potential associated with enrollment growth and other intangibles that do not qualify for separate recognition such as the assembled workforce.


We have selected an April 30th annual goodwill impairment test date.




17



Contents

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JANUARY

January 31, 2018

2023

(Unaudited)



We assigned an indefinite useful life to the accreditation


Title IV Funding
Aspen University and regulatory approvals and the trade name and trademarks as we believe they have the ability to generate cash flows indefinitely. In addition, there are no legal, regulatory, contractual, economic or other factors to limit the intangibles’ useful life and we intend to renew the intangibles, as applicable, and renewal can be accomplished at little cost. We determined all other acquired intangibles are finite-lived and we are amortizing them on eitherUnited States University derive a straight-line basis or using an accelerated method to reflect the pattern in which the economic benefitsportion of their revenue from financial aid received by its students under programs authorized by Title IV of the assetsHEA, which are expected to be consumed. Amortization foradministered by the period of inception through January 31, 2018 was $183,333.


The expected benefitsDOE. When students seek funding from the business acquisition will allow USU, Inc.federal government, they receive loans and grants to achieve its vision of making college affordable again on a much broader scale along with providing various accreditations.


The Company is infund their education under the process of completing its accountingfollowing Title IV Programs: (1) the Federal Direct Loan program, or Direct Loan; (2) the Federal Pell Grant program, or Pell; (3) Federal Work Study and valuations of USU, Inc. and accordingly, the estimated fair values and allocation of purchase price noted above is provisional pending the final valuation of the assets acquired and liabilities assumed which will not exceed one-year in accordance with ASC 805.


The total acquisition costs that AGI incurred was approximately $1,050,000, of which approximately $200,000 was incurred in(4) Federal Supplemental Opportunity Grants. For the fiscal yearyears ended April 30, 20172022, 36.37% of Aspen University’s and $850,00028.06% for United States University's cash-basis revenue for eligible tuition and fees was incurredderived from Title IV Programs.

Return of Title IV Funds
An institution participating in Title IV Programs must correctly calculate the current year.  


The resultsamount of operationsunearned Title IV Program funds that have been disbursed to students who withdraw from their educational programs before completion and must return those unearned funds in a timely manner, no later than 45 days of USU are included in the Company’s consolidated statement of operations from the date of acquisition of December 1, 2017. The following supplemental unaudited pro forma combined information assumesthe school determines that the acquisitions had occurred asstudent has withdrawn. Under the DOE regulations, failure to make timely returns of the beginningTitle IV Program funds for 5% or more of each period present:


 

 

For the Year Ended
April 30,
2017

 

 

For the Nine Months Ended
October 31,
2017

 

 

 

(unaudited)

 

 

(unaudited)

 

Revenue

 

$

18,038,474

 

 

$

10,719,546

 

Net Loss 

 

$

(5,444,205

)

 

$

(3,521,086

)

Loss per common share- basic and diluted

 

$

(0.47

)

 

 

$(0.26

)


The pro forma financial information is not necessarily indicative of the results that would have occurred if these acquisitions had occurredstudents sampled on the dates indicated or thatinstitution's annual compliance audit in either of its two most recently completed fiscal years can result in the future.

institution having to post a letter of credit in an amount equal to 25% of its required Title IV returns during its most recently completed fiscal year. If unearned funds are not properly calculated and returned in a timely manner, an institution is also subject to monetary liabilities or an action to impose a fine or to limit, suspend or terminate its participation in Title IV Programs.
Approval to Confer Degrees
Aspen University is a Delaware corporation and is approved to operate in the State of Delaware. Aspen University is authorized by the Arizona State Board for Private Postsecondary Education in the State of Arizona to operate as a degree-granting institution for all degrees. Aspen University is authorized to operate as a degree-granting institution for bachelor degrees by the Texas Higher Education Coordinating Board in the State of Texas. Aspen University has been granted Optional Expedited Authorization as a postsecondary educational institution in Tennessee for its Bachelor of Science in Nursing (Pre-Licensure) degree program. Aspen University has received a License for its Bachelor of Science in Nursing (Pre-Licensure) degree program to operate in the state of Florida by the Commission for Independent Education of the Florida Department of Education. United States University is a Delaware corporation and is authorized by the California Bureau for Private Postsecondary Education to operate as a degree-granting institution for all degrees.

Note 11. Subsequent Events

Aspen Group, Inc.
15% Senior Secured Note and Warrants
On May 12, 2023, Aspen Group, Inc. completed a private offering of $12.4 million aggregate principal amount of 15% Senior Secured Debentures ("Debentures") due 2026. Of the $12.4 million of principal, $11.0 million was funded with the remainder recorded as debt discount. A portion of the proceeds from the Debentures ($5 million plus accrued interest) were used to fully repay the outstanding borrowings under the 2018 Revolving Credit Facility in addition to paying expenses associated with this offering; the remaining proceeds will be used for working capital needs. The Company also reimbursed the investors for expenses incurred in relation to any legal expenses, due diligence and investment documentation of $90,000 in advance of entering into the Debentures. After the discount, fees, expenses and the repayment of the 2018 Revolving Credit Facility, $3.4 million was made available to the Company as unrestricted cash, and $2.0 million was deposited into a restricted cash account (see covenants discussion below).
The Debentures bear cash interest from May 12, 2023 at an annual rate of 15% payable monthly, beginning on May 1, 2023. The interest rate is subject to increase to 20% upon the occurrence of an event of default. The Debentures will mature on May 12, 2026 unless earlier redeemed. The Debentures are subject to monthly redemptions beginning in November 2023.
The Company may prepay after one year, or any time after May 12, 2024 at 105%.
26

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

The investors also received warrants to purchase 2.2 million shares of common stock, representing 8% of the outstanding common stock at closing, at an exercise provide of $0.01 per share. These warrants have a three-year term and contain anti-dilution protection.
The Debentures contain covenants, including covenants that require the Company to maintain $2 million of restricted cash, maintain at least $20 million of accounts receivable at all times, and maintain enumerated quarterly revenue and quarterly Adjusted EBITDA amounts.
Junior Secured Convertible Promissory Notes
On May 10, 2023, Aspen Group, Inc. agreed to increase the coupon of the two outstanding $5 million convertible promissory notes from an annual rate of 12% to 14% payable monthly, beginning on May 12, 2023, as consideration to the holders of the 2022 Notes who have agreed to subordinate their security interests therein to the security interests granted to the holders of the Debentures.

Voluntarily delist common stock from The Nasdaq Global Market
On March 13, 2023, Aspen Group, Inc. notified Nasdaq of the Company’s decision to voluntarily delist its common stock from The Nasdaq Global Market. On March 23, 2023, the Company filed a Form 25 with the SEC on or about March 23, 2023, thereby terminating trading of its common stock on The Nasdaq Global Market. The Company intends to file a Form 15 with the SEC to suspend the Company’s reporting obligations under Sections 12(g) and 15(d) of the Securities Exchange Act of 1934. The reasons for this decision consist of the anticipated financial savings and lower operating costs, reduced management time commitment for compliance and reporting activities, and a simplified corporate governance structure.

As a result of the foregoing developments, the Company's common stock is now quoted on the OTC Pink Market ("OTC Pink") operated by OTC Markets Group Inc. (the “OTC”). The Company expects that its common stock will be traded on the OTCQB. The Company intends to continue to provide information to its stockholders and to take such actions within its control to enable its common stock to be quoted in the OTCQB or on another OTC market so that a trading market may continue to exist for its common stock. There is no guarantee, however, that a broker will continue to make a market in the common stock and that trading of the common stock will continue on an OTC market or otherwise.
2022 Revolving Credit Facility
On March 14, 2023, the one-year, $20 million secured Revolving Promissory Note and Security Agreements with the same two unaffiliated Lenders of the 2022 Convertible Notes expired and were not renewed.
Aspen UniversityRegulatory Matters
On February 1, 2023, AGI received notification that Aspen University had been issued a Show Cause Directive by DEAC requiring Aspen University to prove why its current accreditation should not be withdrawn and to require Aspen University to undergo a special visit by a team of DEAC evaluators. Show Cause is an enforcement action focused on specific areas of perceived non-compliance to which Aspen must respond through narrative, documentation, and other evidence within the specific remediation timeframe.
DEAC informed Aspen University that certain areas of concern raise serious questions as to Aspen University’s ongoing compliance with DEAC Accreditation Standards III.D., V.A., X.B., XI.E., and DEAC Procedures under Part Two, Section XVII.E, including curricula and instructional materials; student achievement; reputation; operations; and notifications. These call into question Aspen University’s organizational integrity, administrative capacity, and ability to serve students in a manner that complies with DEAC standards. The letter also required the University to submit certain information to DEAC prior to February 16, 2023, and to constituents within seven business days, and permits continuance of DEAC’s monitoring of monthly financial reports. Aspen has complied with the request for monthly reporting timely each month.
To date, Aspen University has provided multiple regulatory bodies with requested records and data and Aspen University will willingly comply with the DEAC's continued oversight through the show cause period. The maximum length of the show cause
27

Table of Contents
ASPEN GROUP, INC. AND SUBSIDIARIES
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
January 31, 2023
(Unaudited)

remediation period is up to two years or 150% of the length of the Institution’s longest program. DEAC expects to schedule its review of Aspen University's response to the show cause directive and the associated record within the next six to nine months. During the show cause remediation period, Aspen University remains fully accredited. DEAC has provided Aspen with a due date for submission of its response to the Show Cause Directive, May 19, 2023, and scheduled a site visit for June 13, 2023.

On February 8, 2023, Aspen University received notification from the DOE that effective February 7, 2023 the DOE had placed Aspen University on Heightened Cash Management 2 (“HCM2”). Under the HCM2 method of payment, Aspen University may continue to obligate funds under the federal student financial assistance programs authorized by Title IV of HEA.
HCM2 is a step that the DOE can take with institutions to provide additional oversight for a number of financial or federal compliance issues. A school placed on HCM2 no longer receives funds under the Advance Payment Method. After a school on HCM2 makes disbursements to students from its own institutional funds, a Reimbursement Payment Request must be submitted for those funds to the DOE. Subsequent to the receipt of the first financial aid payment under HCM2, Aspen University will be able to submit for financial aid reimbursement once every 30 days. Reimbursement payments could be delayed if the DOE has findings upon review of each of our reimbursement files.
The letter from the DOE stated that the DOE acted in response to the Show Cause Directive from DEAC.
On February 20, 2018, AGI announced that2023, Aspen University is entering the pre-licensure Bachelor of Science in Nursing (BSN) degree program business. Aspen’s first campus will be located in Phoenix, Arizona and the university is targeting to begin enrolling students for the upcoming summer semester.


Aspen’s pre-licensure BSN program is offered as a full-time, three-year (nine semester) program that is specifically designed for students who do not currently hold a state nursing license and have no prior nursing experience. Aspen will admit students into three tracks; 1) High school graduates with no prior college credits, 2) students that have less than 48 general education prerequisites completed, and 3) students that have completed all 48 general education prerequisite credits and are ready to enter the core Nursing courses and clinical experiences.


Related to that announcement, Aspen University has entered into a 92 month lease3rd revised Stipulated Agreement with the Arizona State Board for Private Postsecondary Education which requested transcripts from 1985-2019 and an institutional teach-out plan as well as increased monthly financial reporting requirements. Other requirements from the October 2022 Stipulated Agreement were carried forward to this revised agreement. The revised agreement was in response to the Show Cause Directive from DEAC.

United States University Regulatory Matter
On March 27, 2023, United States University received a totalrequest for information from its institutional accreditor, WSCUC, regarding information on the current financial and operational status of 38,014 rentable square feetthe university in a building complex in Phoenix forlight of both AGI’s delisting from The Nasdaq Global Market and Aspen University’s Show Cause Directive from DEAC. USU provided the pre-licensure program and the enrollment center. The lease commencement date is expected to be in the springrequired information timely on April 4, 2023.
28

Table of 2018 and upon commencement, the monthly payments will be approximately $67,000 per month subject to escalation terms.  During the quarter ended 1-31-18, the Company paid a deposit of $519,000.  








Contents


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.


You should read the following discussion in conjunction with our unaudited consolidated financial statements, which are included elsewhere in this Form 10-Q. Management’s Discussion and Analysis of Financial Condition and Results of Operations containThis Quarterly Report on Form 10-Q contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. FactorsSee "Cautionary Note Regarding Forward Looking Statements" for more information.
Key Terms
In connection with the management of our businesses, we identify, measure and assess a variety of operating metrics. The principal metrics we use in managing our businesses are set forth below:
Operating Metrics
Lifetime Value ("LTV") - is the weighted average total amount of tuition and fees paid by every new student that could cause or contribute to these differences include those discussedenrolls in the Risk Factors containedCompany’s universities, after giving effect to attrition.
Bookings - defined by multiplying LTV by new student enrollments for each operating unit.
Average Revenue per Enrollment ("ARPU") - defined by dividing total bookings by total enrollments for each operating unit.
Operating costs and expenses
Cost of revenue - consists of instructional costs and services and marketing and promotional costs.
Instructional costs - consist primarily of costs related to the administration and delivery of the Company's educational programs. This expense category includes compensation costs associated with online faculty, technology license costs and costs associated with other support groups that provide services directly to the students and are included in cost of revenue.
Marketing and promotional costs - include costs associated with producing marketing materials and advertising, and outside sales costs. Such costs are generally affected by the Annual Reportcost of advertising media, the efficiency of the Company's marketing efforts, and expenditures on Form 10-K filed on July 25, 2017 with the Securitiesadvertising initiatives for new and Exchange Commission,existing academic programs. We engage non-direct response advertising activities, which are expensed as incurred, or the SEC.


All referencesfirst time the advertising takes place, depending on the type of advertising activity. These costs are included in cost of revenue.

General and administrative expense - consists primarily of compensation expense (including stock-based compensation expense) and other employee-related costs for personnel engaged in executive and academic management and operations, finance, legal, tax, information technology, human resources, recruiting, fees for professional services, financial aid processing costs, non-capitalizable courseware and software costs, corporate taxes and facilities costs.
Non-GAAP financial measures:
Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") - is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for a reconciliation of net loss to “we,” “our,” “us,” “AGI,”EBITDA for the three and “Aspen” refernine months ended January 31, 2023 and 2022.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA")- is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for a reconciliation of net loss to Adjusted EBITDA for the three and nine months ended January 31, 2023 and 2022.
Company Overview
Aspen Group, Inc. and its subsidiaries,is an education technology holding company. It operates two universities, Aspen University Inc. (“("Aspen University”University" or "AU") and United States University Inc. (“USU”("United States University" or "USU").
29

Table of Contents
All references to the “Company”, “AGI”, “Aspen Group”, “we”, “our” and “us” refer to Aspen Group, Inc., unless the context otherwise indicates.


Company Overview


Aspen Group, Inc. (together with

AGI leverages its subsidiaries, the “Company” or “AGI”) is a holding company. AGI haseducation technology infrastructure and expertise to allow its two subsidiaries,universities, Aspen University Inc. (“Aspen University”) organized in 1987 and United States University, Inc. (“USU”). On March 13, 2012,to deliver on the Company was recapitalized in a reverse merger.


Aspen Group’s vision is to makeof making college affordable again in America.again. Because we believe higher education should be a catalyst to our students’ long-term economic success, we exert financial prudence by offering affordable tuition that is one of the greatest values in online higher education. In March 2014,AGI’s primary focus relative to future growth is to target the high-growth nursing profession. As of January 31, 2023, 8,349 of 9,956 or 84% of all active students across both universities are degree-seeking nursing students. Of the students seeking nursing degrees, 7,744 are RNs studying to earn an advanced degree, including 5,294 at Aspen University unveiledand 2,450 at USU. In contrast, the remaining 605 nursing students are enrolled in Aspen University’s BSN Pre-Licensure program in the Phoenix, Austin, Tampa, Nashville and Atlanta metros. The year-over-year decrease in the nursing student body resulted principally from the enrollment stoppage in all locations of the pre-licensure program and the reduction in marketing spend by $4.2 million.

Aspen University has been offering a monthly payment plan aimed at reversingthat is available to all students across every online degree program offered, since March 2014. The monthly payment plan is designed so that students will make one fixed payment per month, and that monthly payment is applied towards the college-debt sentence plaguing working-class Americans.total cost of attendance (tuition and fees, excluding textbooks). The monthly payment plan offers bacheloronline undergraduate students (except RN to BSN) the opportunity to pay their tuition and fees at $250/month, for 72 months ($18,000), nursing bachelor students (RN to BSN) $250/month for 39 months ($9,750), masteronline master's students $325/month, for 36 months ($11,700) and online doctoral students $375/month, for 72 months ($27,000), interest free, thereby giving students a monthly payment tuition payment option versus taking out a federal financial aid loan.


United States University (USU) began

USU has been offering monthly payment plans insince the summer of 2017. Today, USU monthly payment plans are available for the online RN to BSN program ($250/month), online MBA/M.A.Ed/MAEd/MSN programs ($325/month), online hybrid Bachelor of Arts in Liberal Studies, Teacher Credentialing tracks approved by the California Commission on Teacher Credentialing ($350/month), and the MSN-FNPonline hybrid Master of Science in Nursing-Family Nurse Practitioner ("FNP") program ($375/month).


Since 1993, Aspen University has been nationallyinstitutionally accredited by the Distance Education and Accrediting Council (“DEAC”), a nationalDEAC, an institutional accrediting agency recognized by the U.S. Department of Education (the “DOE”).and the Council for Higher Education Accreditation. On February 25, 2015,2019, the DEAC informed Aspen University that it had renewed its accreditation for five years to January 2019.


2024.

Since 2009, USUUnited States University has been regionallyinstitutionally accredited by WASC Senior CollegeWSCUC, an institutional accrediting agency recognized by the Department of Education and the Council for Higher Education Accreditation. On July 11, 2022, WSCUC informed United States University Commission. (“WSCUC”).


that it had renewed its accreditation for eight years to Spring 2030.

Both universities are qualified to participate under the Higher Education Act of 1965, as amended (HEA)("HEA") and the Federal student financial assistance programs (Title IV, HEA programs).


USU had a provisional certification resulting from the ownership change of control in connection with the acquisition by AGI on December 1, 2017. The provisional certification expired on December 31, 2020. The institution submitted its recertification application timely in October 2020, and received full certification on May 6, 2022, and a new Program Participation Agreement ("PPA") was issued with an effective period until December 31, 2025. On August 22, 2017, the DOE informed Aspen University of its determination that the institution had qualified to participate under the HEA and the Federal student financial assistance programs (Title IV, HEA programs) and set a subsequent program participation agreement reapplication date of March 31, 2021. On April 16, 2021, the DOE granted provisional certification for a two-year timeframe, and set a subsequent program participation reapplication date of September 30, 2023.

AGI Student Population Overview*


Aspen University’sOverview

AGI’s active degree-seeking student body, increasedincluding AU and USU, declined 27% year-over-year by 49% during the fiscal quarter endedto 9,956 at January 31, 2018,2023 from 4,064 to 6,066 students. United States University’s (USU’s) active degree-seeking student body grew from 212 to 446 students or an increase of 110% from May, 2017 to13,724 at January 2018, highlighted by the College of Nursing growing to 326 students which now represents 73% of USU’s total active student body.


Aspen University’s most popular school is also its School of Nursing, which represents 73% of Aspen’s31, 2022. AU's total active student body similardecreased by 33% year-over-year to 7,232 at January 31, 2023 from 10,736 at January 31, 2022. On a year-over-year basis, USU's total active student body decreased by 9% to 2,724 at January 31, 2023 from 2,988 at January 31, 2022.

Total active student body for the past five quarters is shown below:
30

Table of Contents
Q3'22Q4'22Q1'23Q2'23Q3'23
Aspen University10,736 10,225 9,133 7,973 7,232 
USU2,988 3,109 2,915 2,984 2,724 
Total13,724 13,334 12,048 10,957 9,956 
AGI Nursing Student Population
Students seeking nursing degrees were 8,349, or 84% of total active students at both universities. Of the students seeking nursing degrees, 7,744 are RNs studying to earn an advanced degree, including 5,294 at Aspen University and 2,450 at USU. In contrast, the remaining 605 nursing students are enrolled in Aspen University’s BSN Pre-Licensure program in the Phoenix, Austin, Tampa and Nashville metros. The majority of the year-over-year Aspen University nursing student body decrease is a result of the enrollment stoppage and teach out of the pre-licensure program and the $4.2 million reduction in marketing spend in the third quarter of fiscal 2023 as compared to the same quarter of fiscal 2022.

Nursing student body for the past five quarters are shown below:

Q3'22Q4'22Q1'23Q2'23Q3'23
Aspen University9,116 8,632 7,686 6,640 5,899 
USU2,773 2,890 2,708 2,752 2,450 
Total11,889 11,522 10,394 9,392 8,349 

AGI New Student Enrollments
On a Company-wide basis, new student enrollments were down 40% year-over-year. New student enrollments at AU decreased 47% year-over-year and at USU by 22% year-over-year. New student enrollments were primarily impacted by the enrollment stoppage at our pre-licensure campuses, and the reduction in marketing spend.

New student enrollments for the past five quarters are shown below:

Q3'22Q4'22Q1'23Q2'23Q3'23
Aspen University1,301 1,010 868 784 695 
USU481 525 447 506 374 
Total1,782 1,535 1,315 1,290 1,069 
Bookings Analysis and ARPU
On a year-over-year basis, Q3 Fiscal 2023 Bookings decreased 52%, to $12.6 million from $26.3 million in the prior year. As previously discussed, the pre-licensure enrollment stoppage and the reduction in marketing spend by $4.2 million caused Bookings to decrease year-over-year.
On a year-over-year basis, Q3 Fiscal 2023 ARPU decreased 20% from the prior year period due primarily to a decrease in Bookings at Aspen University in the pre-licensure program.

Third Quarter Bookings1 and Average Revenue Per Enrollment (ARPU)1
Q3'22 Enrollments
Q3'22 Bookings 1
Q3'23 Enrollments
Q3'23 Bookings 1
Percent Change Total Bookings & ARPU 1
Aspen University1,301 $17,776,050 695 $5,901,000 
USU481 $8,571,420 374 $6,664,680 
Total1,782 $26,347,470 1,069 $12,565,680 (52)%
ARPU$14,785 $11,755 (20)%
_____________________
1 “Bookings” are defined by multiplying Lifetime Value (LTV) by new student enrollments for each operating unit. “Average Revenue Per Enrollment” (ARPU) is defined by dividing total Bookings by total new student enrollments for each operating unit.
31

Table of Contents
Set forth below is the description of the Company's two licensure degree programs.
Bachelor of Science in Nursing (BSN) Pre-Licensure Program
Aspen’s BSN Pre-licensure program provides students with opportunities to become a BSN-educated nurse and learn the essential skills needed to practice as a professional registered nurse (RN). Skills lab, clinical simulation, seminars and community-based clinical experiences anchor the curriculum. Upon completion of their studies, including for those involved in the current teach-out of the program, students are eligible to take the National Council Licensure Examination (NCLEX) in the state or territory in which they choose to practice (the NCLEX is the national registered nurse examination used by all states for potential registered nursing licensure). Students provide their state board of nursing applicable forms to the School of Nursing grewand Health Sciences, which completes them on behalf of the individual student, and take the exam in the state in which they choose to practice. Upon passing the NCLEX, students then work with their state Board of Nursing to finalize their professional licensure. As of May 12, 2023, the Arizona State Board of Nursing has licensed 444 Aspen University graduates; 2 of our graduates were licensed by their respective boards of nursing in Oregon, 4 in California, 2 in Montana, 1 in North Carolina, 1 in Illinois, and 2 in Texas.
We designed this program for students who do not currently hold a state registered nurse license and have little to no prior nursing experience. For students with no prior college credits, the total cost of attendance is $52,175 ($41,445 Tuition, $10,730 Fees), not including textbooks.
In September 2022, Aspen University suspended new enrollments in its BSN pre-licensure program in Arizona pursuant to a revised Consent Agreement with the Arizona State Board of Nursing, and it also suspended new enrollments in its BSN pre-licensure program in Florida, Georgia, Tennessee and Texas in connection with the Arizona developments. The teach-out of all remaining students is estimated to be completed in the Phoenix metro area by January 2024 (Q3 Fiscal Year 2024), Nashville-based students as of May 2024 (Q1 Fiscal Year 2025), and Texas- and Florida-based students through September 2024 (Q2 Fiscal Year 2025). A more detailed discussion of the pre-licensure program regulatory environment is included in the regulatory environment section below.
For the three and nine months ended January 31, 2023, 19% and 22% of total consolidated AGI revenue was earned from 2,899its pre-licensure nursing program. For the three and nine months ended January 31, 2022, 24% and 23% of total consolidated AGI revenue was earned from this program.
USU Master of Science in Nursing-Family Nurse Practitioner (MSN-FNP)
USU offers a number of nursing degree programs and other degree programs in health sciences, business & technology and education. Its primary enrollment program is its MSN-FNP which is designed for BSN-prepared registered nurses who are seeking a Nurse Practitioner license. The MSN-FNP is an online-hybrid 48-credit degree program with 100% of the curriculum online, including the curricular component to 4,401 student’s year-over-year,complete 540 clinical and 32 lab hours.
While MSN-FNP lab hours have been done at USU’s San Diego facility through the end of calendar year 2020, the rapid growth of the MSN-FNP program has caused AGI to open an additional immersion location in 2021. Specifically, the Company built-out additional suites at our main facility in Phoenix (by the airport).
Regulatory Environment
On February 1, 2023, AGI received notification that Aspen University had been issued a Show Cause Directive by DEAC requiring Aspen University to prove why its current accreditation should not be withdrawn and to require Aspen University to undergo a special visit by a team of DEAC evaluators. Show Cause is an enforcement action focused on specific areas of perceived non-compliance to which represented 75%Aspen must respond through narrative, documentation, and other evidence within the specific remediation timeframe.
DEAC informed Aspen University that certain areas of concern raise serious questions as to Aspen University’s ongoing compliance with DEAC Accreditation Standards III.D., V.A., X.B., XI.E., and DEAC Procedures under Part Two, Section XVII.E, including curricula and instructional materials; student achievement; reputation; operations; and notifications. These call into question Aspen University’s organizational integrity, administrative capacity, and ability to serve students in a manner that complies with DEAC standards. The letter also requires the University to submit certain information to DEAC prior to February 16, 2023, and to constituents within seven business days, and permits continuance of DEAC’s monitoring of monthly financial reports.
32

Table of Contents

To date, Aspen University has provided multiple regulatory bodies with requested records and data and Aspen University will willingly comply with the DEAC’s continued oversight through the show cause period.The maximum length of the show cause remediation period is up to two years or 150% of the length of the Institution’s longest program. DEAC expects to schedule its review of Aspen University's response to the show cause directive and the associated record within the next six to nine months. During the show cause remediation period, Aspen University remains fully accredited.
On February 8, 2023, Aspen University received notification from the DOE that effective February 7, 2023 the DOE had placed Aspen University on Heightened Cash Management 2 (“HCM2”). Under the HCM2 method of payment, Aspen University may continue to obligate funds under the federal student financial assistance programs authorized by Title IV of HEA.
Heightened Cash Monitoring is a step that the DOE can take with institutions to provide additional oversight for a number of financial or federal compliance issues. A school placed on HCM2 no longer receives funds under the Advance Payment Method. After a school on HCM2 makes disbursements to students from its own institutional funds, a Reimbursement Payment Request must be submitted for those funds to the DOE. Consequently, Aspen University is estimating the next financial aid reimbursement received from the DOE will be delayed until late March 2023 at the earliest. Subsequent to the receipt of the first financial aid payment under HCM2, Aspen University will be able to submit for financial aid reimbursement once every 30 days. Reimbursement payments could be delayed if the DOE has findings upon review of each of our reimbursement files.
The letter from the DOE stated that the DOE acted in response to the Show Cause Directive from DEAC.
On February 20, 2023, Aspen University entered into a 3rd revised Stipulated Agreement with the Arizona State Board for Private Postsecondary Education which requested transcripts from 1985-2019 and an institutional teach-out plan as well as increased monthly financial reporting requirements. Other requirements from the October 2022 Stipulated Agreement were carried forward to this revised agreement. The revised agreement was in response to the Show Cause Directive from the Distance Education Accrediting Commission on February 1, 2023, discussed above.
In March 2022, Aspen University agreed to a disciplinary probation of its pre-licensure nursing program, including suspension of new student admissions and a requirement to meet the Arizona State Board of Nursing’s 80% minimum NCLEX-RN first-time pass rate in 2022. By September 2022, the University recognized it would not be able to meet the 80% pass rate and signed a Revised Consent Agreement with the Arizona State Board of Nursing that provided the program with two years to complete a "teach out" of existing students, meaning that the existing students would be able to complete the program. The agreement also contained an option for the Board to terminate the agreement early if the program "fails to provide minimum instruction and learning opportunities, including clinical opportunities, to meet basic standards of educational practice and legal requirements." If the Arizona State Board of Nursing found that to be the case, it could provide a minimum 10-day notice to the University, after which it could determine that the voluntary surrender is immediately in effect.
On February 23, 2023, the Arizona State Board of Nursing informed the University of its intent to lift the stay of voluntary surrender. Board members expressed concerns regarding public safety and student safeness to practice on exit from the program, including concerns that the program was failing to provide minimum instruction as students were continuing to struggle with passing their NCLEX-RN exam the first time, failing to meet basic standards of educational practice by inadequately ensuring the integrity and proctoring of exams, and improperly using students' work hours to count as clinical hours and counting clinical hours when the students were not in the facilities. Aspen disputed all of these concerns except the one related to the NCLEX-RN first-time pass rate.
It was Aspen’s active degree-seeking student body growth.position that a decision by the Board to conduct such a vote to lift the stay at its scheduled March 2023 meeting would be a breach of the September 2022 Consent Agreement, a breach of the covenant of good faith and fair dealing, and cause Aspen irreparable harm. The lifting of the stay would have closed the program immediately and affected almost 400 students across four states. On March 23, 2023, Aspen University and the Arizona State Board of Nursing signed an Amendment to the September 2022 Consent Agreement that permits the teach-out of the program to continue with heightened oversight and reporting. The University will again hire a Consultant and additionally an Ombudsperson to oversee critical aspects of the program in Arizona including testing and clinical practices. The signed Amendment means that the Arizona-based students are permitted to be taught out through January 2024, Nashville-based students through May 2024, and Texas- and Florida-based students through September 2024.
The Company continues to work with internal and external personnel to cooperate and advocate with regulatory agencies in an effort to resolve the foregoing and other regulatory developments affecting its business.
Accounts Receivable - Monthly Payment Plan ("MPP")
33

Table of Contents
The Company offers several payment options to its students including a monthly payment plan (MPP), installment plans and financial aid. The growth in accounts receivable over the last several years has predominantly been a result of students taking advantage of our groundbreaking monthly payment plan, which we introduced in 2014 at Aspen University and subsequently in Fiscal Year 2018 at USU. At January 31, 2018, Aspen’s School2023, Gross MPP accounts receivable was 86% of Nursing included 2,869 active students intotal gross accounts receivable. Of the RNGross accounts receivable, approximately 49% and 37% relates to BSN programAU and 1,532 active students in the MSN program, RN to MSN Bridge program, or DNP program.


 

 

Aspen University

 

 

United States University

 

 

 

Q3 FY’2018

 

 

Q3 FY’2018

 

New Student Enrollments

 

 

1,164

 

 

 

103

**

Active Student Body

 

 

6,066

 

 

 

446

 

-College of Nursing Students

 

 

4,401

 

 

 

326

 

Monthly Payment Method Students

 

 

4,194

 

 

 

204

 


*

Note: “Active Degree-Seeking Students” are defined as degree-seeking students who were enrolled inUSU MPP accounts receivable, respectively.

The Monthly Payment Plan is a course during the quarter reported, or are registered for an upcoming course.






**

Enrollment results for the two month period from December 1, 2017 – January 31, 2018.


Aspen University New Student Enrollment and Active Degree Seeking Student Body Growth


Since the launch of the BSN marketing campaign in November, 2014, Aspen University’s growthprivate education loan with a 0% fixed rate of newinterest (0% APR) and no down payment. Each month the student enrollments has accelerated significantly. Belowwill make one payment of $250, $325, $350 or $375 (depending on the program) until the program tuition is paid in full. The attractive aspect of being able to pay for a quarterly analysisdegree over a fixed period of the growth of Aspen University’s new student enrollments, as well astime fueled the growth of the active degree seeking student body over the past seven quarters, including the recent quarter ending January 31, 2018.


 

 

New Student Enrollments

 

Active Degree Seeking Student Body*

Fiscal quarter end July 31, 2016

 

621

 

3,252

Fiscal quarter end October 31, 2016

 

811

 

3,726

Fiscal quarter end January 31, 2017

 

825

 

4,064

Fiscal quarter end April 30, 2017

 

986

 

4,681

Fiscal quarter end July 31, 2017

 

1,025

 

5,015

Fiscal quarter end October 31, 2017

 

1,255

 

5,641

Fiscal quarter end January 31, 2018

 

1,164

 

6,066


Aspen University Revenue Summary


Below is a summary of the nursing active degree-seeking student bodyMPP plan and as a percentageresult our short-term and long-term accounts receivable. The MPP is designed so students can build the cost of their degree into their monthly budget.

In Q4 Fiscal 2023, AU and USU offered a one-time opportunity for graduates/alumni still making payments under the MPP, and all other payment types including financial aid, to reduce their outstanding balance by 25% if the balance is paid in full within 30 days of receiving the offer. The program ended on March 1, 2023. Approximately $3.6 million was collected under the program. Of the total active degree-seekingcollected, approximately $1.2 million and $2.4 million was collected at AU and USU, respectively.
Long-Term Accounts Receivable
When a student body oversigns up for the past six fiscal quarters.


 

 

Total Degree-Seeking Active Student Body

 

 

Nursing Degree- Seeking Active Student Body

 

 

Nursing Degree-Seeking Active Student Body (%)

 

 

Quarter ended October 31, 2016

 

 

3,726

 

 

 

2,538

 

 

 

68

%

 

Quarter ended January 31, 2017

 

 

4,064

 

 

 

2,899

 

 

 

71

%

 

Quarter ended April 30, 2017

 

 

4,681

 

 

 

3,363

 

 

 

72

%

 

Quarter ended July 31, 2017

 

 

5,015

 

 

 

3,569

 

 

 

71

%

 

Quarter ended October 31, 2017

 

 

5,641

 

 

 

4,068

 

 

 

72

%

 

Quarter ended January 31, 2018

 

 

6,066

 

 

 

4,401

 

 

 

73

%

 


Monthly Payment Programs Overview


Since the March 2014 monthly payment plan, announcement, 69%there is a contractual amount that the Company can expect to earn over the life of Aspen University’s courses are nowthe student’s program. This full contractual amount cannot be recorded as accounts receivable upon enrollment. As a student takes a class, revenue and the associated accounts receivable is earned over that eight-week class. Some students accelerate their program, taking two classes every eight-week period, and that increases the student’s accounts receivable balance. If any portion of the accounts receivable balance will be paid throughin a period of greater than 12 months, that portion is classified as long-term accounts receivable.

As a result of the growing acceptance of our monthly payment methods (based on courses startedplans, our long-term accounts receivable balance has grown from $11,406,525 at April 30, 2022 to $16,280,621 at January 31, 2023. Generally, students in the USU MSN-FNP program make payments over the last 90 days). Aspen offers two monthly payment programs, a monthly72-month period, and as a result, a portion of USU's 72-month payment plan becomes long-term accounts receivable.
Accounts receivable is considered short-term to the extent the remaining payments are 12 months or less. Payments due in which students make payments every month overgreater than 12 months are considered long-term. Here is a fixed period (36, 39 or 72 months depending ongraphic of both short-term and long-term receivables, as well as contractual value:
ABC
The portion of remaining payments owed for classes taken under a monthly payment plan due in 12 months or lessThe portion of remaining payments owed for classes taken under a monthly payment plan due in greater than 12 monthsExpected future classes
to be taken over
balance of program.
Short-Term
Accounts Receivable
Long-term
Accounts Receivable
Not recorded in
financial statements
The Sum of A, B and C will equal the total cost of the program.
Results of Operations
Set forth below is the degree program), and a monthly installment plan in which students pay three monthly installments (day 1, day 31 and day 61 afterdiscussion of the startresults of each course).


Asoperations of January 31, 2018, Aspen University had a total of 4,194 active students paying tuition through a monthly payment method of which 3,901 active students are paying through a monthly payment plan, and 293 students are paying through a monthly installment plan. Additionally, Aspen University is currently projecting to add approximately 120 active students/month net to its monthly payment programs through fiscal year 2018. The total contractual value of Aspen University’s monthly payment plan students now exceeds $35 million which currently delivers monthly recurring tuition cash payments of approximately $1,000,000.


Finally, as a consequence of monthly payment programs becoming the payment method of choice among the majority of Aspen’s degree-seeking student body, our HEA, Title IV Program revenue dropped from 25% of total cash receipts in fiscal year 2016 to 21% for fiscal year 2017.






Marketing Efficiency Analysis


Aspen has developed a marketing efficiency ratio to continually monitor the performance of its business model.


Revenue per Enrollment (RPE)

Marketing Efficiency Ratio =

—————————————

Cost per Enrollment (CPE)


Cost per Enrollment (CPE)

The Cost per Enrollment measures the marketing investment spent in a given quarter, divided by the number of new student enrollments achieved in that given quarter, in order to obtain an average CPECompany for the quarter measured.


Revenue per Enrollment (RPE)

The Revenue per Enrollment takes each quarterly cohort of new degree-seeking student enrollments, and measures the amount of earned revenue including tuition and fees to determine the average RPE for the cohort measured. For the later periods of a cohort, in particular students four years or older, we have used reasonable projections based off of historical results to determine the amount of revenue we will earn in later periods of the cohort.


We created the reporting to track the CPE and RPE starting in 2012 and can accurately predict the CPE and RPE for each new student cohort. Our current CPE/RPE Marketing Efficiency Ratio is reflected in the below table.


Quarterly New Student Cohort Actuals Data:


CPE/RPE Analysis *

6 Months Out

12 Months Out

2 Years Out

3 Years Out

4+ Years Out

 

 

 

 

 

 

Courses completed

2.24

3.52

5.28

6.48

8

 

 

 

 

 

 

Average RPE

$1,974

$3,078

$4,630

$5,684

$7,000

 

 

 

 

 

 

RPE % earned

28%

44%

66%

81%

100%

 

 

 

 

 

 

Marketing efficiency ratio**

2.3x

3.5x

5.3x

6.5x

8.0x


*

Projection

**

Based on current $876 CPE (six month rolling CPE average)

 

 

 

 


The average RPE is approximately $7,000. Of the $7,000, $6,400 of the RPE is earned through tuition, with the remaining $600 on average earned through miscellaneous fees (includes annual technology fee, withdrawal fees, graduation fees, proctored exams, course specific fees, etc.)


Aspen is projecting to average a Marketing Efficiency Ratio of 8.0x, in other words an 8.0x return on our marketing investment. Third-party companies in the higher education industry that manage the Enrollment and Marketing functions on behalf of Universities (also referred to as Managed Services companies) reportedly average 3-4x return on their marketing investments, meaning that Aspen’s business model is currently performing at approximately double the efficiency level of that sector.


Results of Operations


For the Quarter Ended January 31, 2018 Compared with the Quarter Ended January 31, 2017

Revenue


Revenue from operations for the quarterthree months ended January 31, 20182023 (“2018 Quarter”Q3 Fiscal 2023”) increasedcompared to $5,701,958 from $3,735,626 for the quarterthree months ended January 31, 20172022 (“2017 Quarter”Q3 Fiscal 2022”), an increase of $1,966,332 or 53%.





Cost of Revenues (exclusive of amortization)


The Company’s cost of revenues consists of instructional costs and services and sales and marketing costs.


Instructional Costs and Services


Instructional costs and services for the 2018 Quarter rosenine months ended

January 31, 2023 (“9M Fiscal 2023”) compared to $1,196,949 from $694,884 for the 2017 Quarter, an increasenine months ended January 31, 2022 (“9M Fiscal 2022”).

Revenue
The following table presents selected consolidated statement of $502,065 or 72%. Instructional costs and services for the 2018 Quarteroperations as a percentage of revenue was 21% as(differences due to rounding):
34

Table of Contents
Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Revenue100 %100 %100 %100 %
Operating expenses:
   Cost of revenue (exclusive of depreciation and amortization shown separately below)
         Instructional costs and services34 %26 %32 %25 %
         Marketing and promotional costs%23 %11 %22 %
Total cost of revenue (exclusive of depreciation and amortization shown separately below)35 %49 %43 %47 %
   General and administrative62 %62 %60 %60 %
   Bad debt expense%%%%
   Depreciation and amortization%%%%
Total operating expenses105 %118 %111 %113 %
   Operating loss(5)%(18)%(11)%(13)%
Other income (expense):
   Interest expense(5)%(1)%(4)%(1)%
   Other income, net— %— %— %%
Total other (expense) income, net(5)%(1)%(4)%— %
Loss before income taxes(10)%(18)%(14)%(12)%
Income tax expense— %%— %%
Net loss(10)%(20)%(15)%(13)%
The following tables present our revenue, both per-subsidiary and total:
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
AU$9,535,419 $(3,491,919)(27)%$13,027,338 $31,825,415 $(7,210,426)(18)%$39,035,841 
USU6,038,623 121,163 2%5,917,460 19,717,087 1,436,924 8%18,280,163 
Revenue$15,574,042 $(3,370,756)(18)%$18,944,798 $51,542,502 $(5,773,502)(10)%$57,316,004 
Q3 Fiscal 2023 compared to 19%Q3 Fiscal 2022
AU and USU combined revenue decreased 18% in Q3 Fiscal 2023 compared to Q3 Fiscal 2022.The AU revenue decline year-over-year reflects lower post-licensure enrollments attributed to lower marketing spend initiated in late Q1 Fiscal 2023 and the stoppage of enrollments at our pre-licensure campuses. The active student body at AU decreased from 10,736 at January 31, 2022 to 7,232 at January 31, 2023. This AU revenue decrease was offset by the USU revenue increase due primarily to USU's MSN-FNP program, the USU post-licensure degree program with the highest concentration of students and the highest LTV.
9M Fiscal 2023 compared to 9M Fiscal 2022
AU and USU combined revenue decreased 10% in 9M Fiscal 2023 compared to 9M Fiscal 2022. The AU revenue decline year-over-year reflects the enrollment stoppage at the pre-licensure program campuses and the effect of decreased marketing spend initiated late in Q1 Fiscal 2023. This AU revenue decrease was offset by the USU revenue increase due primarily to USU's
35

Table of Contents
MSN-FNP program. The trend of decreased revenue is expected to continue for the 2017 Quarter.  


Salesremainder of Fiscal Year 2023 given the Company’s recent suspension of new enrollment in its pre-licensure program, which accounted for 22% of its consolidated revenue in 9M Fiscal 2023, and Marketing

Salesthe effect of the decrease in marketing spend.


Cost of revenue (exclusive of depreciation and marketing costs for the 2018 Quarter were $1,468,715amortization shown separately below)
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
Instructional costs and services$5,264,542 $341,394 7%$4,923,148 $16,489,725 $2,230,103 16%$14,259,622 
Marketing and promotional129,613 (4,222,658)(97)%4,352,271 5,456,989 (6,941,577)(56)%12,398,566 
Cost of Revenue (exclusive of depreciation and amortization shown separately below)$5,394,155 $(3,881,264)(42)%$9,275,419 $21,946,714 $(4,711,474)(18)%$26,658,188 
Q3 Fiscal 2023 compared to $664,247Q3 Fiscal 2022
Instructional Costs and Services
Consolidated instructional costs and services for Q3 Fiscal 2023 increased to 34% of revenue from 26% of revenue for Q3 Fiscal 2022, related to the 2017 Quarter,factors described below.
AU instructional costs and services were 36% and 25% of AU revenue for Q3 Fiscal 2023 and Q3 Fiscal 2022, respectively. As a percentage of revenue, instructional costs and services increased due primarily to the inflationary impact on faculty compensation and the need for more instructors in the BSN Pre-Licensure program, which is the result of more students entering the core curriculum. The core curriculum requires an increase in the ratio of $804,468 or 121%. The Company expectsinstructors to students, especially as students enter the clinical portion of the program.
USU instructional costs and services were 30% and 28% of USU revenue for Q3 Fiscal 2023 and Q3 Fiscal 2022, respectively. As a percentage of revenue, instructional costs and services increased due primarily to the growth in the USU MSN-FNP program, which resulted in higher USU clinical immersion-related instructional costs, and the inflationary impact on faculty compensation. We believe our efforts to restructure our marketing and general and administrative operations which began during fiscal 2023 will result in positive annual operating cash flows starting in Fiscal 2024.In Fiscal 2024, the generation of positive operating cash flows will permit the resumption of marketing spend at a level that will renew growth in our post licensure student body.
Marketing and Promotional
Consolidated marketing and promotional costs for Q3 Fiscal 2023 were 1% of revenue compared to rise23% of revenue for Q3 Fiscal 2022. The decrease is primarily the result of is follows the $7.4 million year-over-year reduction in future periods, given we expect to increase monthly marketing spend in associated with the Fiscal 2023 restructuring plan. The restructuring program decreased marketing advertising spend across all programs to over $600,000 during the next fiscal year. In addition, this increasemaintenance levels.A break-down of marketing expense by unit is partially attributed to the additionas follows:
AU marketing and promotional costs represented 1% and 22% of an outside sales forceAU revenue for Q3 Fiscal 2023 and Q3 Fiscal 2022, respectively.
USU marketing and promotional costs represented 2% and 20% of 9 representativesUSU revenue for each Q3 Fiscal 2023 and those salariesQ3 Fiscal 2022, respectively.
Corporate marketing and benefits are includedpromotional costs were $328,941 in the 2018 Quarter numbers.


Gross Profit was 51% of revenues or $2,900,633 for the 2018 Quarter asQ3 Fiscal 2023 compared to 60% of revenues or $2,256,918 for the 2017 Quarter. The reasons for the change are reflected$327,697 in the individual expense items described above.


Costs and Expenses


General and Administrative


General and Administrative costs for the 2018 Quarter were $4,677,359 compared to $2,133,074 during the 2017 Quarter,Q3 Fiscal 2022, an increase of $2,544,285$1,244 or 119%less than 1%. General

9M Fiscal 2023 compared to 9M Fiscal 2022
Instructional Costs and AdministrativeServices
36

Table of Contents
Consolidated instructional costs asand services for 9M Fiscal 2023 increased to 32% of revenue from 25% of revenue for 9M Fiscal 2022, related to the factors described below.
AU instructional costs and services were 34% and 25% of AU revenue for 9M Fiscal 2023 and 9M Fiscal 2022, respectively. As a percentage of revenue, for the 2018 Quarter was 82% compared to 57% during the 2017 quarter.  


The Company incurred $610,219 of one-time costs directly related to the USU acquisition. Excluding the $610,219 one-time USU acquisition expenses, G&A increased sequentially by $900,750. The acquisition of United States University accounted for over three-quarters of the G&A increase, as the company’s non-faculty full-time staff rose from 110 to 142 employees. The majority of the remaining increase was a one-time expense of legal fees related to the HEMG NJ bankruptcy proceeding in which the company is a creditor.


Aspen University also recorded $100,000 as a bad debt reserve, an increase reflective of the increase in revenue and students paying by monthly plans.


Depreciation and Amortization


Depreciation and amortization costs for the 2018 Quarter rose to $347,894 from $132,727 for the 2017 Quarter, an increase of $215,167 or 162%. This increase is substantially due to the amortization of intangible assets from the purchase of USU.


Other Expense, net


Other expense, net for the 2018 Quarter increased to $158,986 from $78,317 in the 2017 Quarter, an increase of $80,669 or 103%. This increase is due to interest paid on the credit facility.


Income Taxes

Income taxes expense (benefit) for the comparable years was $0 as Aspen Group experienced operating losses in both periods. As management made a full valuation allowance against the deferred tax assets stemming from these losses, there was no tax benefit recorded in the statement of operations in both periods.


Net Income (Loss)

Net loss for 2018 Quarter was ($2,147,945) as compared to income of $7,377 for the 2017 Quarter, a decrease of $2,155,322. In the 2018 Quarter, the results for USU have been included as well as all of the costs associated with the acquisition.






For the Nine Months Ended January 31, 2018 Compared with the Nine Months Ended January 31, 2017

Revenue


Revenue from operations for the nine months ended January 31, 2018 (“2018 Period”) increased to $14,796,483 from $9,957,467 for the nine months ended January 31, 2017 (“2017 Period”), an increase of $4,839,016 or 49%.


Cost of Revenues (exclusive of amortization)


The Company’s cost of revenues consists of instructional costs and services increased due primarily to the inflationary impact on faculty compensation and sales and marketing costs.


Instructional Costs and Services


Instructionalthe need for more instructors in the BSN Pre-Licensure program, which is the result of more students entering the core curriculum. The core curriculum requires an increase in the ratio of instructors to students, especially as students enter the clinical portion of the program.

USU instructional costs and services were 29% and 25% of USU revenue for 9M Fiscal 2023 and 9M Fiscal 2022, respectively. As a percentage of revenue, instructional costs and services increased due primarily to the 2018 Period rosegrowth in the USU MSN-FNP program, which resulted in increased immersions at additional campuses, and the inflationary impact on faculty compensation.
Marketing and Promotional
Consolidated marketing and promotional costs for 9M Fiscal 2023 were 11% of revenue compared to $2,893,818 from $1,701,94522% of revenue for 9M Fiscal 2022. This follows the 2017 Period,$1 million reduction in marketing spend in Q1 Fiscal 2022 to ensure sufficient collateral for a surety bond required by the Arizona State Board for Private Postsecondary Education and the $1.1 million quarterly year-over-year reduction in marketing spend in Q3 Fiscal 2023 as part of the restructuring plan. The restructuring program decreased marketing advertising spend across all programs to maintenance levels. A break-down of marketing expense by unit is as follows:
AU marketing and promotional costs represented 10% and 21% of AU revenue for 9M Fiscal 2023 and 9M Fiscal 2022, respectively.
USU marketing and promotional costs represented 6% and 17% of USU revenue for each 9M Fiscal 2023 and 9M Fiscal 2022, respectively.
Corporate marketing and promotional costs were $1,098,288 in 9M Fiscal 2023 compared to $994,681 in 9M Fiscal 2022, an increase of $1,191,873$103,607 or 70%10%.


Sales

General and Marketing

Salesadministrative

Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
General and administrative$9,624,528 $(2,146,959)(18)%$11,771,487 $31,039,666 $(3,319,610)(10)%$34,359,276 
Q3 Fiscal 2023 compared to Q3 Fiscal 2022
Consolidated general and marketingadministrative expense for Q3 Fiscal 2023 was $9,624,528 or 62% of revenue compared to $11,771,487 or 62% of revenue for Q3 Fiscal 2022, a decrease of $2,146,959 or 18%. As part of the Company's recent restructuring plan, which was initiated late Q1 Fiscal 2023, the company eliminated approximately 70 positions within AU and Corporate in Q2 Fiscal 2023, resulting in compensation-related savings of approximately $1.0 million in Q3 Fiscal 2023 as compared to Q3 Fiscal 2022. A break-down of general and administrative expense by unit is as follows:
AU general and administrative expense decreased by $1,086,811 year-over-year and was 38% and 36% of AU revenue for Q3 Fiscal 2023 and Q3 Fiscal 2022, respectively. The decrease in employee-related compensation due to the restructuring program and other cost controls implemented by management, were partially offset by a fee for the 2018 Periodsurety bond required by the Arizona State Board for Private Postsecondary Education, which is being amortized over one year.

USU general and administrative expense decreased by $320,630 year-over-year and was 37% and 43% of USU revenue for Q3 Fiscal 2023 and Q3 Fiscal 2022, respectively. The decrease was primarily due to lower employee-related compensation due to cost controls implemented by management and decreased facilities costs related to the move to the new campus at the end of Q2 Fiscal 2023.

Corporate general and administrative expense was $3.7 million and $4.5 million in Q3 Fiscal 2023 and Q3 Fiscal 2022, respectively. The decrease was primarily due to the impact of the restructuring and planned corporate cost control.
37

Table of Contents

As part of the Company's recent restructuring initiatives, general and administrative compensation savings are expected to be $1.0 million in Q4 Fiscal 2023.
9M Fiscal 2023 compared to 9M Fiscal 2022
Consolidated general and administrative expense for 9M Fiscal 2023 was $31,039,666 or 60% of revenue compared to $34,359,276 or 60% of revenue for 9M Fiscal 2022, a decrease of $3,319,610 or 10%. As part of the Company's recent restructuring plan, which was initiated late Q1 Fiscal 2023, the Company eliminated approximately 70 positions within AU and Corporate, resulting in on-going quarterly compensation-related savings of approximately $1.0 million. Additionally, the Company initiated additional cost controls within the general and administrative functions in Fiscal 2022, which also resulted on 9M Fiscal 2023 savings. A break-down of general and administrative expense by unit is as follows:
AU general and administrative expense decreased $1,305,975 year-over-year and was 39% and 35% of AU revenue for 9M Fiscal 2023 and 9M Fiscal 2022, respectively. The decreases in employee-related compensation due to cost controls implemented by management, were $3,388,996 from $1,788,101partially offset by higher professional fees related to regulatory matters, fee for the 2017 Period, an increasesurety bond required by the Arizona State Board for Private Postsecondary Education, which is being amortized over one year and increases in fixed expenses related to new campus openings in the pre-licensure program.

USU general and administrative expense decreased by $505,570 year-over-year and was 36% and 41% of $1,600,895 or 90%.USU revenue for 9M Fiscal 2023 and 9M Fiscal 2022, respectively. The decrease in employee-related compensation due to cost controls implemented by management and decreased facilities costs related to the move to the new campus at the end of Q2 Fiscal 2023 was partially offset by increases in fixed expenses related to expansion of the USU MSN-FNP program.

Corporate general and administrative expense was $11.6 million and $13.1 million in 9M Fiscal 2023 and 9M Fiscal 2022, respectively. The decrease was primarily due to planned corporate cost control, a reduction in Delaware Franchise Corporate Tax payments and the reversal of stock-based compensation expense for (i) $0.2 million related to a performance award that the Company assessed its performance condition will not be met and (ii) $0.1 million related to a grant forfeited by the resignation of the Chief Nursing Officer, on July 15, 2022, partially offset by higher professional and consultant fees of $0.7 million and a non-recurring severance expense related to the resignation of the Chief Nursing Officer.
Bad debt expense
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
Bad debt expense$450,000$100,00029%$350,000$1,250,000$200,00019%$1,050,000
Based on our review of additional student accounts associated with current period revenue and previously existing student accounts receivable and historical write-off trends, the Company evaluated its reserve methodology and adjusted reserves for AU and USU accordingly.
At AU and USU, $0.4 million and $0.1 million, respectively, of student accounts receivable were written off against the accounts receivable allowance during Q3 Fiscal 2023. The Company expects salesrecorded additional bad debt expense of $100,000 at USU.
At AU and marketing to rise in future periods, given we expect to increase monthly marketing spend to over $600,000USU, $1.0 million and $0.2 million, respectively, of student accounts receivable were written off against the accounts receivable allowance during the 2019 fiscal year.


Gross Profit rose to $8,513,669 for the 2018 Period from $6,467,421 for the 2017 Period.9M Fiscal 2023. The reasons for the change are reflected in the individualCompany recorded additional bad debt expense items described above.


Costs and Expenses


General and Administrative


General and administrative costs for the 2018 Period were $10,975,085 compared to $6,228,554 during the 2017 Period, an increase of $4,746,531 or 76%.


Depreciation and Amortization


$250,000 at USU, offset by a decrease of $50,000 at AU.


Depreciation and amortization costs for
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
Depreciation and amortization$919,152$35,6164%$883,536$2,775,330$295,15112%$2,480,179

For both periods, the 2018 Period increased to $631,969 from $422,782 for the 2017 Period, an increase of $209,187 or 49%.


Other Income (Expense)


Other expense increased to ($303,190) from ($172,615), an increase of $130,575 or 76%. This increaseincludes depreciation which is primarily due to the Q2 Fiscal 2023 commencement of the lease for the Atlanta campus and move to the new USU campus. Related capital expenditures include leasehold improvements and computer equipment. The increase also includes amortization related to internally developed capitalized software placed into service to support the Company's instructional services and the opening of the new campus locations.

38

Table of Contents
Interest expense
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
Interest expense$716,845$536,148297%$180,697$2,008,510$1,654,772468%$353,738

For both periods, interest expense increased due principally to the borrowings under the 2022 Convertible Notes, amortization expense related to the commitment fees paid on the credit facility. undrawn portion of the 2022 Revolving Credit Facility, which are amortized over the one-year term of the loan, and the drawdown and extension of the maturity of the 2018 Credit Facility on August 31, 2021. The commitment fees relate to a 1% fee of $200,000 on the undrawn portion of the 2022 Revolving Credit Facility paid at closing, or March 14, 2022, and another 1% fee of $200,000, which was paid six months from the closing date, or September 14, 2022.

Other (expense) income, net
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
Other income, net$12,847$(1,107)NM$13,954$28,138$(488,616)(95)%$516,754
Other income, increasednet in 9M Fiscal 2022 primarily includes $498,120 related to $140,567 from $1,684, primarily duea litigation settlement on July 21, 2021 offset by the write-off of a related net receivable of $45,329 with the party in this litigation; partially offset by a $36,445 write off of fixed assets.
Income tax expense
Three Months Ended January 31,Nine Months Ended January 31,
2023$ Change% Change20222023$ Change% Change2022
Income tax expense$37,249$(194,361)(84)%$231,610$114,071$(274,449)(71)%$388,520
Income tax expense in Q3 Fiscal 2023 and 9M Fiscal 2023 includes a reserve of approximately $25,000 and $75,000, respectively, for the estimated Fiscal Year 2023 Canada foreign income tax liability which covers the 2023 tax year for which a permanent establishment is in place in Canada. The Company will file an annual Canadian T2 Corporation Income Tax return and related information returns under the Voluntary Disclosure Program with the Canada Revenue Agency ("CRA") to report the ongoing activity of the permanent establishment.
Income tax expense in Q3 Fiscal 2022 and 9M Fiscal 2022 includes a reserve of approximately of approximately $227,000 and $375,000, respectively, related to the interestforeign income earned ontax liability. These reserves are included in "Accrued expenses" in the $900,000 promissory note from USU and from the releaseconsolidated balance sheets. In 9M Fiscal 2022, approximately $300,000 of the warrant derivativereserve relates to the estimate of the Canada foreign income tax liability of $52,500.


Income Taxes

Income taxes expense (benefit) forwhich covers the 2018 Period and 2017 Period2013 through 2021 tax years during which a permanent establishment was $0 as Aspen Group experienced operating losses in both periods. As management made a full valuation allowance againstplace in Canada. This amount has not yet been remitted to the deferred tax assets stemming from these losses, there was no tax benefit recorded in the statement of operations in both periods.


Net Loss

Net loss for the 2018 Period was ($3,396,575) as compared to ($381,530) for the 2017 Period, an increase in the loss of $3,015,045.




CRA.


Non-GAAP Financial Measures


The following

This discussion and analysis includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of AGI nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.


Our management uses and relies on EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBITDA,Gross Profit, which are non-GAAP financial measures. We believe that both management, analysts and shareholders benefit from referring to the following non-GAAP financial measures in planning, forecasting and analyzing future periods. Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate and assess our core operating results from period-to-period comparison.after removing
39

Table of Contents
the impact of items that affect comparability. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described excluded items.


AGI defines Adjusted EBITDA as earnings (or loss) from operations before the items in the table below including non-recurring charges of $85,853. Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period-to-period after removing the impact of items of a non-operational nature that affect comparability.


below.

We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measuremeasures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between Aspen GroupAGI and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each company under applicable SEC rules.


rules of the Securities and Exchange Commission.


EBITDA and Adjusted EBITDA

AGI defines Adjusted EBITDA as EBITDA excluding: (1) bad debt expense; (2) stock-based compensation; and (3) non-recurring charges or gains. The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA and of net loss margin to Adjusted EBITDA Margin.
Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Net loss$(1,555,040)$(3,733,997)$(7,563,651)$(7,457,143)
Interest expense, net714,801 180,642 2,004,086 350,838 
Taxes37,249 231,610 114,071 388,520 
Depreciation and amortization919,152 883,536 2,775,330 2,480,179 
EBITDA116,162 (2,438,209)(2,670,164)(4,237,606)
Bad debt expense450,000 350,000 1,250,000 1,050,000 
Stock-based compensation394,510 700,697 899,176 1,965,567 
Non-recurring charges - Severance— — 125,000 19,665 
Non-recurring charges (income) - Other— 49,310 717,299 (345,056)
Adjusted EBITDA$960,672 $(1,338,202)$321,311 $(1,547,430)
Net loss Margin(10)%(20)%(15)%(13)%
Adjusted EBITDA Margin6%(7)%1%(3)%

In Q3 Fiscal 2023, the increase in Adjusted EBITDA was attributable to the savings from the restructuring plan, which includes reducing marketing spend to maintenance levels and a reduction in general and administrative costs associated with planned cost control and a reduction in headcount, partially offset by lower revenue at AU related to the enrollment stoppage for the pre-licensure program and decreased AU online enrollments related to decreased marketing spend.
In Q3 Fiscal 2022, Non-recurring income - Other includes the write-off of a net receivable of $45,329 related to litigation settled on July 21, 2021, which is included in "other (expense) income, net."
In 9M Fiscal 2023, the increase in Adjusted EBITDA is attributable to a decrease in marketing spend and planned cost controls and headcount reductions, which were part of the restructuring initiative in Q1 Fiscal 2023, partially offset by lower AU revenue. Non-recurring charges - Severance of $125,000 relates to the resignation of the Chief Nursing Officer, effective July 15, 2022. Non-recurring charges - Other of $717,299 includes non-recurring professional fees and consulting costs.
In 9M Fiscal 2022, Non-recurring income - Other of $345,056 includes $498,120 of a litigation settlement amount received on July 21, 2021 offset by the write-off of a related net receivable of $45,329 with the party in this litigation, which is included in "other (expense) income, net."
The following tables present a reconciliation of net income (loss) allocable to common shareholders,EBITDA and Adjusted EBITDA and of net loss margin to the Adjusted EBITDA Margin by subsidiary:
40

Table of Contents
Three Months Ended January 31, 2023
ConsolidatedAGI CorporateAUUSU
Net income (loss)$(1,555,040)$(4,836,956)$1,536,456 $1,745,460 
Interest expense, net714,801 716,824 (945)(1,078)
Taxes37,249 4,058 22,858 10,333 
Depreciation and amortization919,152 64,874 739,563 114,715 
EBITDA116,162 (4,051,200)2,297,932 1,869,430 
Bad debt expense450,000 — 225,000 225,000 
Stock-based compensation394,510 352,207 32,389 9,914 
Adjusted EBITDA$960,672 $(3,698,993)$2,555,321 $2,104,344 
Net income (loss) Margin(10)%NM16 %29 %
Adjusted EBITDA Margin%NM27 %35 %

Three Months Ended January 31, 2022
ConsolidatedAGI CorporateAUUSU
Net income (loss)$(3,733,997)$(5,020,149)$941,437 $344,715 
Interest expense, net180,642 180,682 — (40)
Taxes231,610 951 230,660 (1)
Depreciation and amortization883,536 47,536 738,172 97,828 
EBITDA(2,438,209)(4,790,980)1,910,269 442,502 
Bad debt expense350,000 — 225,000 125,000 
Stock-based compensation700,697 616,166 56,880 27,651 
Non-recurring charges - Other49,310 49,310 — — 
Adjusted EBITDA$(1,338,202)$(4,125,504)$2,192,149 $595,153 
Net income (loss) Margin(20)%NM%%
Adjusted EBITDA Margin(7)%NM17 %10 %
The Adjusted EBITDA Margin improved to 6% in Q3 Fiscal 2023 from (7)% in Q3 Fiscal 2022 due primarily to the decrease in marketing spend and planned cost controls and headcount reductions associated with the restructuring initiative in Q1 Fiscal 2023.
Nine Months Ended January 31, 2023
ConsolidatedAGI CorporateAUUSU
Net income (loss)$(7,563,651)$(14,885,752)$2,394,912 $4,927,189 
Interest expense, net2,004,086 2,008,340 (2,762)(1,492)
Taxes114,071 18,008 65,355 30,708 
Depreciation and amortization2,775,330 203,176 2,242,077 330,077 
EBITDA(2,670,164)(12,656,228)4,699,582 5,286,482 
Bad debt expense1,250,000 — 675,000 575,000 
Stock-based compensation899,176 731,268 121,651 46,257 
Non-recurring charges - Severance125,000 125,000 — — 
Non-recurring charges - Other717,299 717,299 — — 
Adjusted EBITDA$321,311 $(11,082,661)$5,496,233 $5,907,739 
41

Table of Contents
Net income (loss) Margin(15)%NM%25 %
Adjusted EBITDA Margin%NM17 %30 %

Nine Months Ended January 31, 2022
ConsolidatedAGI CorporateAUUSU
Net income (loss)$(7,457,143)$(14,537,849)$4,605,707 $2,474,999 
Interest expense, net350,838 353,193 (1,739)(616)
Taxes388,520 3,363 383,867 1,290 
Depreciation and amortization2,480,179 116,720 2,082,972 280,487 
EBITDA(4,237,606)(14,064,573)7,070,807 2,756,160 
Bad debt expense1,050,000 — 725,000 325,000 
Stock-based compensation1,965,567 1,732,412 149,773 83,382 
Non-recurring charges - Severance19,665 — — 19,665 
Non-recurring charges - Other(345,056)107,635 (452,691)— 
Adjusted EBITDA$(1,547,430)$(12,224,526)$7,492,889 $3,184,207 
Net income (loss) Margin(13)%NM12 %14 %
Adjusted EBITDA Margin(3)%NM19 %17 %
Adjusted Gross Profit
GAAP Gross Profit is revenue less cost of revenue less amortization expense. The Company defines Adjusted Gross Profit as GAAP Gross Profit adjusted to exclude amortization expense. The following table presents a reconciliation of GAAP financial measure:


 

 

For the Quarters Ended

 

 

 

January 31,

 

 

 

2018

 

 

2017

 

Net income (loss)

 

$

(2,147,945

)

 

$

7,377

 

Interest expense, net of interest income

 

 

211,486

 

 

 

78,317

 

Depreciation & amortization

 

 

347,894

 

 

 

132,727

 

EBITDA (loss)

 

 

(1,588,565

)

 

 

218,421

 

Bad debt expense

 

 

132,644

 

 

 

(25,680

Acquisition expense

 

 

610,219

 

 

 

 

Non-recurring charges

 

 

85,853

 

 

 

146,809

 

Stock-based compensation

 

 

162,544

 

 

 

96,498

 

Adjusted EBITDA (Loss)

 

$

(597,305

)

 

$

436,048

 




Gross Profit to Adjusted Gross Profit:

Three Months Ended January 31,Nine Months Ended January 31,
2023202220232022
Revenue$15,574,042 $18,944,798 $51,542,502$57,316,004
Cost of Revenue5,394,155 9,275,419 21,946,71426,658,188
Adjusted Gross Profit10,179,887 9,669,379 29,595,78830,657,816
Less amortization expense included in cost of revenue:
   Intangible asset amortization23,653 22,174 68,02260,162
   Call center software/website amortization474,605 419,026 1,415,4481,255,169
Total amortization expense included in cost of revenue498,258 441,200 1,483,4701,315,331
GAAP Gross Profit$9,681,629 $9,228,179 $28,112,318$29,342,485


GAAP Gross Profit as a percentage of revenue62 %49 %55%51%
Adjusted Gross Profit as a percentage of revenue65 %51 %57%53%

For both periods, GAAP Gross profit and gross margin increased due primarily to lower cost of revenue associated with the decrease in marketing spend and planned cost controls, which was part of the restructuring initiative in Q1 Fiscal 2023.
Liquidity and Capital Resources



Cash flow information

42

Table of Contents
A summary of ourthe Company's cash flows is as follows:


 

 

For the

 

 

 

Nine Months Ended

 

 

 

January 31,

 

 

 

2018

 

 

2017

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

$

(3,654,947

)

 

$

(99,042

)

Net cash used in investing activities

 

 

(3,031,667

)

 

 

(571,856

)

Net cash provided by financing activities

 

 

7,733,477

 

 

 

784,200

 

Net increase in cash and cash equivalents

 

$

1,046,863

 

 

$

113,302

 


Nine Months Ended January 31,
20232022
Net cash (used in) provided by
   Operating activities$(4,456,117)$(7,719,760)
   Investing activities(1,681,706)(3,734,670)
   Financing activities(251,298)5,191,034 
   Net decrease in cash$(6,389,121)$(6,263,396)

Net Cash Provided by (Used in)Used in Operating Activities


Net cash used in operating activities during the 2018 Period totaled ($3,654,947) and resulted primarily by thedecreased from $7,719,760 in 9M Fiscal 2022 to $4,456,117 in 9M Fiscal 2023. Our net loss for 9M Fiscal 2023 adjusted for non-cash activities was a use of ($3,396,575), offset by approximately $1,200,000cash of $1.9 million. Approximately $2.6 million of cash used in non-cash itemsoperations is attributed to increased working capital which is attributed to increases in short-term and approximately $1,100,000long-term monthly payment plan accounts receivable.
The decrease in operating assets and liabilities. The most significant item change operating assets and liabilities wascash from changes in working capital primarily consists of an increase in accounts receivable of $4,534,118 whichand other current assets, and a decrease in due to students, partially offset by increases in deferred revenue, prepaid expenses, accounts payable and other current liabilities. The increase in accounts receivable is primarily attributed to the growth in revenues from students paying through the monthly payment plan.plan as well as the timing of billings for class starts and the timing of cash receipts. The most significantincrease in other current assets is due to a $0.6 million reserve required by our former MPP credit card processor which is expected to be returned to the universities before the end of Calendar Year 2023. Due to students decreased due to the timing of billings for class starts and refunds to students for class drops and other adjustments, which were made close to quarter end. Deferred revenue increased primarily due to timing of billings for class starts, specifically class starts close to quarter end. The decrease in prepaid expenses is due primarily the amortization of prepaid student educational software licenses and employee used software licenses, and a fee for the surety bond required by the Arizona State Board for Private Postsecondary Education, which is being amortized over one year. Accounts payable increased due to timing of payments.
The decrease in non-cash items wereadjustments primarily consists of lower stock-based compensation expense related to (i) the reversal of $242,708 of amortization expense related to the Chief Executive Officer's performance-based RSU grant that the Company assessed will not be met as of July 31, 2022; and (ii) the reversal of $139,431 of amortization expense related to the resignation of the Chief Nursing Officer on July 15, 2022; and lower tenant improvement reimbursements associated with the commencement of the Atlanta campus lease. Offsetting these decreases is higher depreciation and amortization expense associated with the opening of $631,969new campus locations and stock compensation expensethe implementation of $466,468.


Net cash used in operating activities during the 2017 Period totaled ($99,042)internal use software.

The Company expects working capital and resulted primarily by non-cash items of $925,740 and a net change in operating assets and liabilities of ($668,252), reduced by the net loss of $381,530. The most significant item change operating assets and liabilities was an increase inlong-term student accounts receivable to trend lower for the remainder of $2,331,140 which is primarily attributed to the growthFiscal 2023 as fewer students enroll in revenues from students paying through the monthly payment plan. The most significant non-cash items were depreciationplan due to decreased marketing spend. Additionally, there may be working capital volatility from quarter to quarter, regarding the timing of financial aid payments relating to HCM2 (effective February 7, 2023) and amortization expensethe timing and size of $422,782student course starts that impact deferred revenue and stock compensation expense of $253,833.


accounts receivable balances.


Net Cash Provided by (Used in)Used in Investing Activities


Net cash used in investing activities duringin 9M Fiscal 2023 decreased from 9M Fiscal 2022 primarily due to lower capital expenditures associated with the 2018 Period totaled ($3,031,667) mostly attributed to cash paidopening of pre-licensure locations including tenant improvements and a decrease in the USU acquisition and the purchase of property and equipment.


courseware updates.

Net Cash (Used in) Provided By Financing Activities
Net cash used in investingfinancing activities during the 2017 Period totaled ($571,856) mostly attributedin 9M Fiscal 2023 related to the increase in software.


Net Cash Provided By (Used In) Financing Activities


Net cash provided bypayment of a 1% commitment fee of $200,000 on the 2022 Revolving Credit Facility, which was due six months from the closing date of March 14, 2022, or September 14, 2022, since the revolving credit facility has not been replaced; and $60,833 of deferred financing activities during the 2018 Period totaled $7,733,477 which reflects primarily the cash provided by the senior secured term loan.


Net cash provided by financing activities during the 2017 Period totaled $784,200 which reflects the increase duecosts related to the new $3,000,000 line of credit, of which $1,250,000 has been drawn,Lender's legal fees incurred during August 2022 for the 2022 Convertible Note. This was partially offset by 11,840 shares the buybackCompany sold under the Equity Distribution Agreement with Northland Securities, Inc. and received net proceeds of warrants for $400,000.


$9,535. The Equity Distribution Agreement was canceled on October 11, 2022.


Liquidity and Capital Resource Considerations


Historically, our primary sourceResources

43

Table of liquidity is cash receipts from tuition and the issuances of debt and equity securities. More recently, we were able to secure traditional non-convertible debt. The primary uses of cash are payroll related expenses, professional expenses, and instructional and marketing expenses. We did issue a convertible note as part of the USU purchase price since the seller wanted the potential for capital appreciation and required part of the purchase price evidenced by a convertible note. On July 25, 2017, the Company finalized a $10 million senior secured term loan, $5 million of which was funded at the close and $2.5 million with the closing of the USU acquisition.


As of March 15, 2018, the Company had a cash balance of approximately $3.7 million. With the cash from the Company’s senior secured term loan of $10 million in total (of which $7.5 million has been funded) and the growth in the Company revenues, the Company believes that it has sufficient cash to allow the Company to meet its operational expenditures for at least the next 12 months.



Contents


Our cash balances are kept liquid to support our growing infrastructure needs. The majority of our cash is concentrated in large financial institutions.


Financing Arrangements
15% Senior Secured Debentures
On May 12, 2023, Aspen Group, Inc. completed a private offering of $12.4 million aggregate principal amount of 15% Senior Secured Note ("Debentures") due 2026 of which $11.0 million was funded. A portion of the proceeds from these Debentures were used to repay the outstanding borrowings under the $5 million Credit Facility and to pay expenses associated with this offering; the remaining proceeds will be used for working capital needs other than $2 million required to be kept as restricted cash. The Company also reimbursed the investors for expenses incurred in relation to any legal expenses, due diligence and investment documentation of $90,000. The Debentures mature on May 12, 2026 unless earlier redeemed. After the discount, fees, expenses and the repayment of the 2018 Revolving Credit Facility, $3.4 million was made available to the Company as unrestricted cash, and $2.0 million was deposited into a restricted cash account.
The investors also received warrants to purchase 2.2 million shares of common stock, representing 8% of the outstanding common stock at closing, at an exercise provide of $0.01 per share. These warrants have a three-year term and contain anti-dilution protection.
The Company may prepay the Debentures any time after May 12, 2024 at 105%. The Debentures accrue interest at a rate of 15% per annum, payable monthly, subject to increase to 20% upon the occurrence of an event of default. The Debentures contain covenants,including covenants that require (1) the Company to keep $2 million of restricted cash; (2) the Company to have at least $20 million of student accounts receivable at all times; and (3) the Company to meet enumerated quarterly revenue and quarterly Adjusted EBITDA amounts.

Convertible Note
On March 14, 2022, the Company closed an offering of a $10 million convertible notes. Subsequent to the closing of the $10 million convertible notes, $5 million was restricted as collateral for a surety bond, which was required by the Arizona State Board for Private Postsecondary Education. The remaining $5 million was used for general corporate purposes, including funding the Company’s then expansion of its BSN Pre-Licensure nursing degree program.

Credit Facility
On March 14, 2022, the Company extended its $5 million Credit Facility by one additional year to November 4, 2023, at an increased interest rate of 14% per annum. The Company used these funds for general business purposes.
At both January 31, 2023 and April 30, 2022, there were $5 million of borrowings outstanding under the Credit Facility.
This facility was repaid with proceeds from the Debentures.
Sufficiency of Working Capital
As of May 12, 2023, the Company had $4.0 million of unrestricted cash on hand. We expect that with reductions associated with the restructuring plan and other corporate cost reductions, we will have sufficient cash to meet our working capital needs for the next 12 months.
Restructuring
In late Q1 Fiscal 2023, we implemented a restructuring plan that resulted in significant cash benefits for the Company starting in Q2 Fiscal 2023 and continuing for the remainder of the fiscal year. There are two key components of the plan. First, in the second quarter we scaled back marketing advertising spend to maintenance levels of $150,000 per quarter which resulted in savings of $3.7 million in Q2 Fiscal 2023 and savings of $3.8 million in Q3 Fiscal 2023. The savings estimates are based on a normalized marketing ad spend run rate of $4.0 million per quarter. Second, the plan resulted in the elimination of approximately 70 positions mostly within the general and administrative functions at Aspen University and AGI. As a result, there were additional restructuring savings of $600,000 in Q2 Fiscal 2023 and savings of $1.0 million in Q3 Fiscal 2023. The estimated general and administrative spend reductions are based on our Q1 Fiscal 2023 expenses. Total spend reductions were $4.5 million in Q2 Fiscal 2023 and $4.9 million in Q3 Fiscal 2023.
44

Table of Contents

Capital and other expenditures
The Company anticipates that it will need to make capital and other expenditures in connection with on-going operations.
Critical Accounting Policies and Estimates


In response to financial reporting release FR-60, Cautionary Advice Regarding Disclosure About Critical Accounting Policies, from the SEC, we have selected our more subjective accounting estimation processes for purposes of explaining the methodology used in calculating the estimate, in addition to the inherent uncertainties pertaining to the estimate and the possible effects on our financial condition. There

At January 31, 2023, there were no material changes to our principalcritical accounting policies and estimates. A full listing of our critical accounting policies and estimates duringis described in the period covered by this report.


Related Party Transactions


See Note 9 to"Critical Accounting Policies and Estimates" of our Annual Report on Form 10-K for the unaudited consolidated financial statements included hereinfiscal year ended April 30, 2022 and listed here below:

Revenue Recognition and Deferred Revenue
Accounts Receivable and Allowance for additional description of related party transactions that had a material effect on our unaudited consolidated financial statements.


Doubtful Accounts Receivable

Goodwill and Intangibles
Stock-based compensation
Off Balance Sheet Arrangements

We do

The Company does not engage inhave any activities involving variable interest entities or off-balance sheet arrangements.


New Accounting Pronouncements


See Note 2 to our unaudited consolidated financial statements included herein for discussionarrangements as of recent accounting pronouncements.


January 31, 2023.

Cautionary Note Regarding Forward Looking Statements


Statements.

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the effect of our restructuring initiatives including efforts to reduce expenditures such as general and administrative and marketing expenses and the anticipated results and benefits of these efforts, the use of proceeds from our recent financing transaction and the perceived advantages of such uses, our plans to restructure expenditures and the anticipated benefits of those efforts, including achieving positive annual operating cash flows starting in Fiscal 2024 and the resumption of marketing spend at a level that will renew growth in our post licensure student growth, projected Marketing Efficiency Ratio, overall growthbody, and our liquidity. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that couldmay cause actual results to differ materially from those in thethese forward-looking statements include, without limitation, our ability to enroll new students and generate revenue given the failureprior sharp reduction in marketing, the continued demand of nursing students for our programs, our ability to successfully resolve the regulatory matters involving agencies in Arizona and elsewhere, our ability to maintain regulatory approvals, regulatory issues, competition, ineffective media and/orand grow enrollments in our active programs with increased marketing, failurethe continued attraction of online learning as the COVID-19 pandemic has receded, student attrition, national and local economic factors including a possible recession and increasing unemployment, uncertainties arising from high inflation, Federal Reserve interest rate increases, the banking crisis, and the Russian invasion of Ukraine including its effect on the U.S. economy, the competitive impact from the trend of major non-profit universities using online education and consolidation among our competitors, and the myriad of risks which may affect our ability to maintain growth in degree seeking studentsour operations, advance our business plan, manage our costs, grow our revenue, and the integration of USU.repay our obligations as and when they come due. Further information on the risks and uncertainties affecting our risk factorsbusiness is contained in our filings with the SEC, including thethis Form 10-Q and our Annual Report on Form 10-K filed on July 25, 2017. Any forward-looking statement made by us in this report speaks only as offor the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them.fiscal year ended April 30, 2022. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

RISK.

Not applicable.


ITEM 4. CONTROLS AND PROCEDURES


PROCEDURES.

Evaluation of Disclosure Controls and Procedures.
45

Table of Contents
Our management carried out an evaluation, with the participation of our Principal Executive Officer and Principal Financial Officer, required by Rule 13a-15 or 15d-15 of the Securities Exchange Act of 1934 (the “Exchange Act”) of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) or 15d-15(e) under the Exchange Act. Based on their evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting.
There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.





46



Table of Contents
PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS


From time to time,time-to-time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. There wereDuring the reporting period, there have been no material changes to ourthe description of legal proceedings as describedset forth in the Company’sour Annual Report on Form 10-K duringfor the period covered by this report.   

fiscal year ended April 30, 2022.


ITEM 1A. RISK FACTORS


Not applicable to smaller reporting companies.

None.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

From November 1, 2017, to January 31, 2018, 87,470 shares were issued in connection with the cashless exercise of 178,917 warrants with exercise prices ranging from 3.99 to 6.00 per share.  These securities were issued without registration under the Securities Act of 1933 in reliance upon the exemption provided in Section 3(a)(9) thereunder.


From November 1, 2017 to January 31, 2018, 64,584 shares were issued in connection with the exercise of warrants with exercise prices ranging from $2.40 to $6.00 per share.  The Company received $162,504 from these cash exercises. During the quarter ended January 31, 2018, 5,000 shares of common stock were issued to each of two consultants working on the Arizona campus initiative. These securities were issued without registration under the Securities Act of 1933 in reliance upon the exemption provided in Section 4(a)(2) and Rule 506(b) thereunder.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.


ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION


Not applicable.

None.


ITEM 6. EXHIBITS

See the Exhibit Index at the end of this report.






47


SIGNATURES


Pursuant to the requirementsTable of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Aspen Group, Inc.

March 15, 2018

By:

/s/ Michael Mathews

Michael Mathews

Chief Executive Officer

(Principal Executive Officer)


March 15, 2018

By:

/s/ Janet Gill

Janet Gill

Chief Financial Officer

(Principal Financial Officer)







Contents


EXHIBIT INDEX


 

 

 

 

 

Incorporated by Reference

 

Filed or Furnished

Exhibit #

 

Exhibit Description

 

 

Form

 

Date

 

 

Number

 

Herewith

3.1

   

Certificate of Incorporation, as amended

  

 

10-Q

   

3/9/17

  

 

3.1

   

 

3.2

 

Bylaws, as amended

 

 

 

 

 

 

 

 

 

Filed

4.1

 

Form of Convertible Note

 

 

8-K

 

12/1/17

 

 

4.1

 

 

10.1

 

Employment Agreement with Michael Mathews dated November 2, 2016*

 

 

10-Q

 

3/9/17

 

 

10.1

 

 

10.2

 

Loan and Security Agreement – Runway+

 

 

8-K

 

7/28/17

 

 

10.1

 

 

10.3

 

Registration Rights Agreement – Runway

 

 

8-K

 

7/28/17

 

 

10.2

 

 

10.4

 

Warrant Agreement – Runway +

 

 

8-K

 

7/28/17

 

 

10.3

 

 

10.5

 

Form of Registration Rights Waiver

 

 

10-Q

 

9/14/17

 

 

10.4

 

 

10.6

 

Promissory Note dated March 8, 2017 – Linden Finance

 

 

10-K

 

7/25/17

 

 

10.1

 

 

10.7

 

Employment Agreement dated June 11, 2017 – St. Arnauld*

 

 

8-K

 

6/15/17

 

 

10.1

 

 

10.8

 

Asset Purchase Agreement dated May 13, 2017 +

 

 

8-K

 

5/18/17

 

 

10.1

 

 

10.9

 

Employment Agreement dated November 24, 2014 - Gerard Wendolowski*

 

 

10-K

 

7/28/15

 

 

10.19

 

 

10.10

 

Employment Agreement dated November 24, 2014 - Janet Gill*

 

 

10-K

 

7/28/15

 

 

10.18

 

 

10.11

 

2012 Equity Incentive Plan, as amended*

 

 

 

 

 

 

 

 

 

Filed

10.12

 

Form of Stock Purchase Agreement

 

 

8-K

 

4/10/17

 

 

10.1

 

 

10.13

 

Form Waiver of Registration Rights Agreement

 

 

8-K

 

5/30/17

 

 

10.1

 

 

10.14

 

Form of Registration Rights Agreement

 

 

8-K

 

4/10/17

 

 

10.2

 

 

10.15

 

Loan Agreement dated August 31, 2016 – Cooperman

 

 

8-K

 

9/7/16

 

 

2.1

 

 

10.16

 

Revolving Promissory Note dated August 31, 2016 – Cooperman

 

 

8-K

 

9/7/16

 

 

2.2

 

 

10.17

 

Warrant dated August 31, 2016 – Cooperman

 

 

8-K

 

9/7/16

 

 

3.1

 

 

10.18

 

Note Conversion Agreement dated April 16, 2016 – Mathews

 

 

10-K

 

7/27/16

 

 

10.4

 

 

10.19

 

Letter Agreement with Warrant Holders for Reduced Exercise Price and Early Exercise 2016

 

 

10-K

 

7/27/16

 

 

10.19

 

 

31.1

 

Certification of Principal Executive Officer (302)

 

 

 

 

 

 

 

 

 

Filed

31.2

 

Certification of Principal Financial Officer (302)

 

 

 

 

 

 

 

 

 

Filed

32.1

 

Certification of Principal Executive and Principal Financial Officer (906)

 

 

 

 

 

 

 

 

 

Furnished**

101.INS

 

XBRL Instance Document

 

 

 

 

 

 

 

 

 

Filed

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

Filed

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

Filed

———————

Incorporated by ReferenceFiled or
Furnished
Herewith
Exhibit #Exhibit DescriptionFormDateNumber
Certificate of Incorporation, as amended10-K7/9/20193.1
Certificate of Amendment to Articles of Incorporation - authorized shares8-K7/12/20223.1
Bylaws, as amended10-Q3/15/20183.2
Certification of Principal Executive Officer (302)Filed
Certification of Principal Financial Officer (302)Filed
Certification of Principal Executive and Principal Financial Officer (906)Furnished**
101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCHInline XBRL Taxonomy Extension Schema DocumentFiled
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentFiled
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentFiled
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentFiled
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentFiled
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

_____________________
*

Management contract or compensatory plan or arrangement.

**

This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

+

Certain schedules appendices and exhibits to this agreementother attachments have been omitted. The Company undertakes to furnish the omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementallyschedules and attachments to the Securities and Exchange Commission staffSEC upon request.

Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to Aspen Group, Inc., at the address on the cover page of this report, Attention: Corporate Secretary.





29


48

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Aspen Group, Inc.
May 16, 2023By:/s/ Michael Mathews
Michael Mathews
Chief Executive Officer
(Principal Executive Officer)


May 16, 2023By:/s/ Matthew LaVay
Matthew LaVay
Chief Financial Officer
(Principal Financial Officer)

49